arxspanID,cellLineName,cclfPubID,cclfID,preliminaryDiagnosis,finalDiagnosis,primaryDisease,Subtype,NCIt,tumorType,effort,Subsource,sampleCollectionSite,age,cancerType,WES,RNAseq,proteomics,methylation,WGS,pairedGermline,pairedTumor,genomicTriad,gender,race,treatmentHistory,cultureType,cultureMedium
ACH-002420,CCLFPANC0005T,CCLF_PANC_0005_T,AA22T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,Unknown,,,3D,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002421,CCLFPANC0006T,CCLF_PANC_0006_T,AA23T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,Unknown,,,,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002422,CCLFPANC0008T,CCLF_PANC_0008_T,AA25T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,Unknown,,,3D,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002423,CCLFPANC0010T,CCLF_PANC_0010_T,AA31T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,Unknown,,,3D,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002424,CCLFPANC0014T,CCLF_PANC_0014_T,AA42T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,Unknown,,,3D,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002425,CCLFPANC0020T,CCLF_PANC_0020_T,AA55T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,Unknown,,,2D Suspension,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002448,CCLFPANC0021T,CCLF_PANC_0021_T,AA56T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,Unknown,,,3D,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002426,CCLFPANC0022T,CCLF_PANC_0022_T,AA59T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,Unknown,,,3D,Pancreas Organoid Media (WnT3A CM:Basic Medium:Panc: Rspondinl CM) (5:4:1) + 5% FBS
ACH-002443,CCLFUPGI0002T2,CCLF_UPGI_0002_T2,AB002T_BT,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002444,CCLFUPGI0003T,CCLF_UPGI_0003_T,AB018T_ASC,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,Unknown,,,2D Suspension,CM
ACH-002445,CCLFUPGI0004T,CCLF_UPGI_0004_T,AB018T_PF,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,Test,Unknown,,,2D Adherent,CM
ACH-002446,CCLFUPGI0005T,CCLF_UPGI_0005_T,AB035T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Pleural Cavity,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-002417,CCLFNEURO0015T,CCLF_NEURO_0015_T,BT1009,Adenocarcinoma: lung primary,lung adenocarcinoma,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Suspension,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002418,CCLFNEURO0017T,CCLF_NEURO_0017_T,BT1018,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002408,CCLFNEURO0003T,CCLF_NEURO_0003_T,BT632,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,66,,,,,,,,,Test,Unknown,,,2D Adherent,CM
ACH-002409,CCLFNEURO0006T,CCLF_NEURO_0006_T,BT890,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RETM + 5% FBS + 3% RETM supplement + 1% Pen-Strep + 20% Gentamicin + 25ng/ml Cholera toxin + 250ng/ml Fungizone
ACH-002410,CCLFNEURO0007T,CCLF_NEURO_0007_T,BT921,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002411,CCLFNEURO0008T,CCLF_NEURO_0008_T,BT923,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002412,CCLFNEURO0009T,CCLF_NEURO_0009_T,BT924,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002413,CCLFNEURO0010T,CCLF_NEURO_0010_T,BT953,Cardiac Sarcoma,spindle cell sarcoma,Sarcoma,Spindle Cell Sarcoma,Sarcoma (C9118),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002414,CCLFNEURO0011T,CCLF_NEURO_0011_T,BT954,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Suspension,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002415,CCLFNEURO0013T,CCLF_NEURO_0013_T,BT987,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,NeuroCult NS-A Basal Medium
ACH-002416,CCLFNEURO0014T,CCLF_NEURO_0014_T,BT990,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002449,CCLFNEURO0021T,CCLF_NEURO_0021_T,CCLF_KL1023T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Suspension,NeuroCult NS-A Basal Medium + NeuroCult NS-A Proliferation Supplement 10 % + 20ng/ml bFGF + 20ng/ml EGF + 2ug/ml Heparin
ACH-002450,CCLFNEURO0023T,CCLF_NEURO_0023_T,CCLF_KL1058T,oligodendroglioma,,Brain Cancer,Oligodendroglioma,Oligodendroglioma (C3288),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002451,CCLFNEURO0026T,CCLF_NEURO_0026_T,CCLF_KL1073T,glioma: high grade,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002452,CCLFNEURO0027T,CCLF_NEURO_0027_T,CCLF_KL1077T ,GBM,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,
ACH-002506,CCLFNEURO0039T,CCLF_NEURO_0039_T,CCLF_KL1081T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
ACH-002507,CCLFNEURO0040T,CCLF_NEURO_0040_T,CCLF_KL1089T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,CM
ACH-002453,CCLFNEURO0031T,CCLF_NEURO_0031_T,CCLF_KL1100T,atypical meningioma,meningioma,Brain Cancer,Meningioma: atypical,Atypical Meningioma (C4723),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002454,CCLFNEURO0032T,CCLF_NEURO_0032_T,CCLF_KL1101T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002455,CCLFNEURO0034T,CCLF_NEURO_0034_T,CCLF_KL1116T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,Neurosphere (NSA)
ACH-002456,CCLFNEURO0035T,CCLF_NEURO_0035_T,CCLF_KL1118T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002457,CCLFNEURO0037T,CCLF_NEURO_0037_T,CCLF_KL1122T,anaplastic meningioma,anaplastic meningioma,Brain Cancer,Meningioma: anaplastic,Anaplastic (Malignant) Meningioma (C4051),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002438,CCLFPEDS0026T,CCLF_PEDS_0026_T,CCLF_PEDS1012T,Wilms tumor,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Metastasis,Sample Derivation,CCLF,Lung,Unknown,Pediatric,,,,,,,,Test,Unknown,,,2D Adherent,CM
ACH-002403,CCLFMELM0001T,CCLF_MELM_0001_T,CY001T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Skin,53,,,,,,,,,,Male,,,2D Adherent,RETM + 5% FBS + 3% RETM supplement + 1% Pen-Strep + 20% Gentamicin + 25ng/ml Cholera toxin + 250ng/ml Fungizone
ACH-002404,CCLFMELM0002T,CCLF_MELM_0002_T,CY002T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Skin,77,,,,,,,,,,Male,,,2D Adherent,RETM + 5% FBS + 3% RETM supplement + 1% Pen-Strep + 20% Gentamicin + 25ng/ml Cholera toxin + 250ng/ml Fungizone
ACH-002405,CCLFMELM0003T,CCLF_MELM_0003_T,CY003T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Skin,67,,,,,,,,,,Male,,,2D Adherent,SMBM + 5% SMGM-2 Single Quot + 1% Pen-Strep + 500ng/ml Fungizone + 20ug/ml Gentamicin
ACH-002407,CCLFMELM0005T,CCLF_MELM_0005_T,CY006T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Skin,72,,,,,,,,,Test,Male,,,2D Adherent,RETM + 5% FBS + 3% RETM supplement + 1% Pen-Strep + 20% Gentamicin + 25ng/ml Cholera toxin + 250ng/ml Fungizone
ACH-002440,CCLFTHYR0008T,CCLF_THYR_0008_T,JL50,Papillary Thyroid Cancer,,Thyroid Cancer,Carcinoma: papillary,Thyroid Gland Papillary Carcinoma (C4035),Metastasis,Sample Derivation,CCLF,Pleura,Unknown,,,,,,,,,,Unknown,,,2D Adherent,NeuroCult NS-A Basal Medium
ACH-002427,CCLFPEDS0001T,CCLF_PEDS_0001_T,PEDS005T_PF,Renal Medullary Carcinoma,,Kidney Cancer,Renal Medullary Carcinoma,Kidney Medullary Carcinoma (C7572),Metastasis,Sample Derivation,CCLF,Kidney,Unknown,Pediatric,,,,,,,,,,,,,
ACH-001164,CCLFPEDS0003T,CCLF_PEDS_0003_T,PEDS015T,Undifferentiated Sarcoma,undifferentiated sarcoma,Sarcoma,Undifferentiated,Sarcoma (C9118),Metastasis,Sample Derivation,CCLF,Soft Tissue,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,DMEM:F12 (3:1) + 2mM L-glutamine + 5ug/ml Insulin + 0.4ug/ml Hydrocortisone + 550ug/ml Pen-Strep + 5uM Y-27632 + 8.6ng/ml Cholera toxin + 10ng/ml EGF + 250ng/ml Fungizone + 10ug/ml Gentamicin
ACH-001433,CCLFPEDS0008T,CCLF_PEDS_0008_T,PEDS092T_PF,Epithelioid sarcoma,epitelioid sarcoma,Sarcoma,Epithelioid,Sarcoma (C9118),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,SMGM
ACH-001429,CCLFPEDS0009T,CCLF_PEDS_0009_T,PEDS110T_PF,Ewing sarcoma,ewing sarcoma,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,DMEM:F12 (3:1) + 2mM L-glutamine + 5ug/ml Insulin + 0.4ug/ml Hydrocortisone + 550ug/ml Pen-Strep + 5uM Y-27632 + 8.6ng/ml Cholera toxin + 10ng/ml EGF + 250ng/ml Fungizone + 10ug/ml Gentamicin
ACH-001428,CCLFPEDS0010T,CCLF_PEDS_0010_T,PEDS117T_PF,Ewing sarcoma,ewing sarcoma,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,DMEM:F12 (3:1) + 2mM L-glutamine + 5ug/ml Insulin + 0.4ug/ml Hydrocortisone + 550ug/ml Pen-Strep + 5uM Y-27632 + 8.6ng/ml Cholera toxin + 10ng/ml EGF + 250ng/ml Fungizone + 10ug/ml Gentamicin
ACH-002431,CCLFPEDS0014T1,CCLF_PEDS_0014_T1,PEDS157T_AT,Neuroblastoma,neuroblastoma,Neuroblastoma,Unknown,Neuroblastoma (C3270),Primary,Sample Derivation,CCLF,Autonomic Ganglia,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,RETM + 5% FBS + 3% RETM supplement + 1% Pen-Strep + 20% Gentamicin + 25ng/ml Cholera toxin + 250ng/ml Fungizone
ACH-002433,CCLFPEDS0019T,CCLF_PEDS_0019_T,PEDS182T,Osteosarcoma,osteosarcoma,Bone Cancer,Osteosarcoma,Osteosarcoma (C9145),Primary,Sample Derivation,CCLF,Bone,Unknown,Pediatric,,,,,,,,,Male,,,2D Adherent,SMBM + 5% SMGM-2 Single Quot + 1% Pen-Strep + 500ng/ml Fungizone + 20ug/ml Gentamicin
ACH-002435,CCLFPEDS0022T,CCLF_PEDS_0022_T,PEDS196T,Wilms Tumor,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002436,CCLFPEDS0023T,CCLF_PEDS_0023_T,PEDS204T,Wilms Tumor,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,CM
ACH-002419,CCLFOVPA0001T,CCLF_OVPA_0001_T,SM045T_WitP,Ovarian Cancer,,Ovarian Cancer,Unknown,Ovarian Carcinoma (C4908),Primary,Sample Derivation,CCLF,Ovary,Unknown,,,,,,,,,Test,Female,,,2D Suspension,WITP + WIT-P Supplement 5%
,CCLFPANC0007T,CCLF_PANC_0007_T,AA24T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0009T,CCLF_PANC_0009_T,AA29T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,CCLFPANC0011T,CCLF_PANC_0011_T,AA34T,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0012T,CCLF_PANC_0012_T,AA39T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0013T,CCLF_PANC_0013_T,AA40T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,CCLFPANC0015T,CCLF_PANC_0015_T,AA43T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,CCLFPANC0016T,CCLF_PANC_0016_T,AA45T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0017T,CCLF_PANC_0017_T,AA46T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,CCLFPANC0018T,CCLF_PANC_0018_T,AA49T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0019T,CCLF_PANC_0019_T,AA53T_2,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0023T,CCLF_PANC_0023_T,AA61T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0024T,CCLF_PANC_0024_T,AA66T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0007T,CCLF_UPGI_0007_T,AB040T_PF,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Pleural Cavity,Unknown,,,,,,,,,Test,,,,3D,CM
,CCLFUPGI0008T,CCLF_UPGI_0008_T,AB053T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0009T,CCLF_UPGI_0009_T,AB058T_ASC,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Peritoneal Cavity,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFNEURO0001T,CCLF_NEURO_0001_T,BT584,Adenocarcinoma:Colon primary,colon adenocarcinoma,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,F Media
,CCLFNEURO0002T,CCLF_NEURO_0002_T,BT607,GBM: gliosarcoma variant,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,F Media
,CCLFNEURO0005T,CCLF_NEURO_0005_T,BT856,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,CM
,CCLFPANC0025T,CCLF_PANC_0025_T,CCLF_AA1003T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Peritoneal Cavity,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0026T,CCLF_PANC_0026_T,CCLF_AA1005T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0028T,CCLF_PANC_0028_T,CCLF_AA1016T_ASC,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0029T,CCLF_PANC_0029_T,CCLF_AA1018T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0030T,CCLF_PANC_0030_T,CCLF_AA1019T,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0031T,CCLF_PANC_0031_T,CCLF_AA1020T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0032T,CCLF_PANC_0032_T,CCLF_AA1022T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0033T,CCLF_PANC_0033_T,CCLF_AA1024T_PF,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,Test,,,,3D,Pancreas Organoid
,CCLFPANC0034T,CCLF_PANC_0034_T,CCLF_AA1027T_ASC,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0035T,CCLF_PANC_0035_T,CCLF_AA1028T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0037T,CCLF_PANC_0037_T,CCLF_AA1035T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0038T,CCLF_PANC_0038_T,CCLF_AA1036T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0039T,CCLF_PANC_0039_T,CCLF_AA1040T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0040T,CCLF_PANC_0040_T,CCLF_AA1043T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0041T,CCLF_PANC_0041_T,CCLF_AA1045T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0042T,CCLF_PANC_0042_T,CCLF_AA1047T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0043T,CCLF_PANC_0043_T,CCLF_AA1048T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0044T,CCLF_PANC_0044_T,CCLF_AA1052T,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0045T,CCLF_PANC_0045_T,CCLF_AA1055T_ASC,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0046T,CCLF_PANC_0046_T,CCLF_AA1057T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0047T,CCLF_PANC_0047_T,CCLF_AA1058T,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0048T,CCLF_PANC_0048_T,CCLF_AA1060T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0049T,CCLF_PANC_0049_T,CCLF_AA1062T,Pancreatic Adenocarcinoma,pancreatic ductal adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0050T,CCLF_PANC_0050_T,CCLF_AA1066T_ASC,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0051T,CCLF_PANC_0051_T,CCLF_AA1067T_ASC,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0052T,CCLF_PANC_0052_T,CCLF_AA1070T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,Test,,,,3D,Pancreas Organoid
,CCLFPANC0053T,CCLF_PANC_0053_T,CCLF_AA1076T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0054T,CCLF_PANC_0054_T,CCLF_AA1078T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0055T,CCLF_PANC_0055_T,CCLF_AA1080T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0056T,CCLF_PANC_0056_T,CCLF_AA1086T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0057T,CCLF_PANC_0057_T,CCLF_AA1088T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0058T,CCLF_PANC_0058_T,CCLF_AA1101T_ASC,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0059T,CCLF_PANC_0059_T,CCLF_AA1103T_ASC_OPAC_p2,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFPANC0061T,CCLF_PANC_0061_T,CCLF_AA1105T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0062T,CCLF_PANC_0062_T,CCLF_AA1106T_OPAC_p2_3D,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFPANC0063T,CCLF_PANC_0063_T,CCLF_AA1108T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0064T,CCLF_PANC_0064_T,CCLF_AA1109T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0065T,CCLF_PANC_0065_T,CCLF_AA1111T_OPAC_p2_3D,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFPANC0066T,CCLF_PANC_0066_T,CCLF_AA1112T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPANC0067T,CCLF_PANC_0067_T,CCLF_AA1122T_ASC_OPAC_p2_3D,Pancreatic Adenocarcinoma,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFPANC0068T,CCLF_PANC_0068_T,CCLF_AA1124T,Pancreatic Adenocarcinoma,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Omentum,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0011T,CCLF_UPGI_0011_T,CCLF_AB1004T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,Test,,,,3D,Pancreas Organoid
,CCLFUPGI0012T,CCLF_UPGI_0012_T,CCLF_AB1008T_ASC,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0013T,CCLF_UPGI_0013_T,CCLF_AB1013T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,Test,,,,3D,Pancreas Organoid
,CCLFUPGI0014T,CCLF_UPGI_0014_T,CCLF_AB1016T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0015T,CCLF_UPGI_0015_T,CCLF_AB1017T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0016T,CCLF_UPGI_0016_T,CCLF_AB1018T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0017T,CCLF_UPGI_0017_T,CCLF_AB1021T_ASC,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0020T,CCLF_UPGI_0020_T,CCLF_AB1030T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0021T,CCLF_UPGI_0021_T,CCLF_AB1031T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0022T,CCLF_UPGI_0022_T,CCLF_AB1036T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0023T,CCLF_UPGI_0023_T,CCLF_AB1039T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0024T,CCLF_UPGI_0024_T,CCLF_AB1040T_PF,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Thoracic Cavity,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0025T,CCLF_UPGI_0025_T,CCLF_AB1041T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0026T,CCLF_UPGI_0026_T,CCLF_AB1049T_ASC,Stomach Adenocarcinoma [STAD],gastric poorly-differentiated carcinoma,Gastric Cancer,Carcinoma,Gastric Carcinoma (C4911),Unknown,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0027T,CCLF_UPGI_0027_T,CCLF_AB1053T_ASC,Esophogeal carcinoma [ESCA],esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0028T,CCLF_UPGI_0028_T,CCLF_AB1054T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0030T,CCLF_UPGI_0030_T,CCLF_AB1066T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0031T,CCLF_UPGI_0031_T,CCLF_AB1067T_OPAC_p3_3D,Stomach Adenocarcinoma [STAD],,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFUPGI0032T,CCLF_UPGI_0032_T,CCLF_AB1068T_ASC,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0033T,CCLF_UPGI_0033_T,CCLF_AB1070T_ASC_OPAC_p2_3D,Esophogeal carcinoma [ESCA],,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
ACH-002447,CCLFUPGI0006T,CCLF_UPGI_0006_T,AB039T,Esophogeal carcinoma [ESCA],esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,Unknown,,,3D,Pancreas Organoid
,CCLFUPGI0036T,CCLF_UPGI_0036_T,CCLF_AB1083T_PF ,Stomach Adenocarcinoma [STAD],,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFUPGI0010T,CCLF_UPGI_0010_T,AB059T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0019T,CCLF_UPGI_0019_T,CCLF_AB1029T_ASC,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0034T,CCLF_UPGI_0034_T,CCLF_AB1075T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFNEURO0041T,CCLF_NEURO_0041_T,CCLF_KL1094T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Neurosphere (NSA)
,CCLFNEURO0042T,CCLF_NEURO_0042_T,CCLF_KL1105T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLFNEURO0043T,CCLF_NEURO_0043_T,CCLF_KL1117T,Lung Carcinoma,lung adenocarcinoma,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,Test,,,,2D Suspension,Ar5
ACH-002697,CCLFNEURO0045T,CCLF_NEURO_0045_T,CCLF_KL1148T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Neurosphere (NSA)
,CCLFNEURO0046T,CCLF_NEURO_0046_T,CCLF_KL1149T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
ACH-002700,CCLFNEURO0047T,CCLF_NEURO_0047_T,CCLF_KL1154T,GBM,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Neurosphere (NSA)
,CCLFNEURO0049T,CCLF_NEURO_0049_T,CCLF_KL1187T_AR5,Melanoma,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,
,CCLFNEURO0050T,CCLF_NEURO_0050_T,CCLF_KL1194T_RETM_p7_2D,Meningioma,,Brain Cancer,Meningioma,Meningioma (C3230),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,
,CCLFNEURO0052T,CCLF_NEURO_0052_T,CCLF_KL1212T_NSA_p5_Laminin,Meningioma,,Brain Cancer,Meningioma,Meningioma (C3230),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,
,CCLFUPGI0035T,CCLF_UPGI_0035_T,CCLF_AB1081T,Esophogeal carcinoma [ESCA],esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFUPGI0037T,CCLF_UPGI_0037_T,CCLF_cRCRF1001T,Stomach Adenocarcinoma [STAD],stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLFPEDS0034T,CCLF_PEDS_0034_T,CCLF_PEDS1041T,alveolar rhabdomyosarcoma,alveolar rhabdomyosarcoma,Sarcoma,Rhabdomyosarcoma: alveolar,Alveolar Rhabdomyosarcoma (C3749),Unknown,Sample Derivation,CCLF,Pleural Cavity,Unknown,Pediatric,,,,,,,,,,,,2D Adherent,HT Media Screen
,CCLFPEDS0035T,CCLF_PEDS_0035_T,CCLF_PEDS1046T,alveolar rhabdomyosarcoma,alveolar rhabdomyosarcoma,Sarcoma,Rhabdomyosarcoma: alveolar,Alveolar Rhabdomyosarcoma (C3749),Unknown,Sample Derivation,CCLF,Pleural Cavity,Unknown,Pediatric,,,,,,,,,,,,2D Adherent,Ar5
,CCLFUPGI0039T,CCLF_UPGI_0039_T,CCLF_RCRF1050T_OPAC_p2_3D,Esophogeal carcinoma [ESCA],,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Unknown,Sample Derivation,CCLF,Unknown,Unknown,Adult Rare,,,,,,,,,,,,,
,CCLFUPGI0040T,CCLF_UPGI_0040_T,CCLF_RCRF1053T_OPAC_p3_3D,Stomach Adenocarcinoma [STAD],,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Unknown,Unknown,Adult Rare,,,,,,,,,,,,,
,CCLFKIPA0001T,CCLF_KIPA_0001_T,CCLF_SS1002T,ccRCC,renal clear cell carcinoma,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Unknown,Sample Derivation,CCLF,Kidney,Unknown,,,,,,,,,,,,,,Ar5
,CCLFKIPA0002T,CCLF_KIPA_0002_T,CCLF_SS1009T,ccRCC,kidney renal clear cell carcinoma,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Unknown,Sample Derivation,CCLF,Kidney,Unknown,,,,,,,,,Test,,,,2D Adherent,HT Media Screen
,CCLFMELM0004T,CCLF_MELM_0004_T,CY004T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Sample Derivation,CCLF,Axilla,Unknown,,,,,,,,,,,,,,Ar5
,CCLFMELM0006T,CCLF_MELM_0006_T,CY012T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLFMELM0007T,CCLF_MELM_0007_T,CY014T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,2D Adherent,RETM
,CCLFMELM0008T,CCLF_MELM_0008_T,CY016T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLFMELM0009T,CCLF_MELM_0009_T,CY017T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLFMELM0010T,CCLF_MELM_0010_T,CY018T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLFMELM0011T,CCLF_MELM_0011_T,CY020T,Melanoma,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLFMELM0012T,CCLF_MELM_0012_T,CY025T_1_AR5_p5_2D,Melanoma,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFMELM0012T2,CCLF_MELM_0012_T2,CY025T_2_RETM_p5_2D,Melanoma,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,CCLFTHYR0001T,CCLF_THYR_0001_T,JL16,Anaplastic Thyroid Cancer,anaplastic thyroid cancer,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,,CM
,CCLFTHYR0002T,CCLF_THYR_0002_T,JL27,Anaplastic Thyroid Cancer,thyroid cancer,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Primary,Sample Derivation,CCLF,Thyroid,Unknown,,,,,,,,,Test,,,,2D Adherent,CM
,CCLFTHYR0003T,CCLF_THYR_0003_T,JL30,Anaplastic Thyroid Cancer,unknown,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,,CM
,CCLFTHYR0004T,CCLF_THYR_0004_T,JL36,Anaplastic Thyroid Cancer,,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,,CM
,CCLFTHYR0005T,CCLF_THYR_0005_T,JL37,Anaplastic Thyroid Cancer,anaplastic thyroid cancer,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,,CM
,CCLFTHYR0006T,CCLF_THYR_0006_T,JL42,Anaplastic Thyroid Cancer,,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,,CM
ACH-001423,CCLFPEDS0002T,CCLF_PEDS_0002_T,PEDS012T,Wilms Tumor,,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,Pediatric,,,,,,,,,Unknown,,,,CM
ACH-001425,CCLFPEDS0004T,CCLF_PEDS_0004_T,PEDS018T,Undifferentiated Sarcoma,spindle cell sarcoma,Sarcoma,Spindle Cell Sarcoma,Sarcoma (C9118),Primary,Sample Derivation,CCLF,Ascites,Unknown,Pediatric,,,,,,,,,Unknown,,,,CM
ACH-001427,CCLFPEDS0007T1,CCLF_PEDS_0007_T1,PEDS078T_1,Ewing sarcoma,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Metastasis,Sample Derivation,CCLF,Bone,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,SMBM + 5% FBS + Insulin + 0.5ml EGF + 1ml hFGF-B
,CCLFPEDS0013T,CCLF_PEDS_0013_T,PEDS149T,Embryonal rhabdomyosarcoma ,embryonal rhabdomyosarcoma,Sarcoma,Rhabdomyosarcoma: embryonal,Embryonal Rhabdomyosarcoma (C8971),Primary,Sample Derivation,CCLF,Soft Tissue,Unknown,Pediatric,,,,,,,,,,,,,Ar5
ACH-001767,CCLFPEDS0018T,CCLF_PEDS_0018_T,PEDS172T_PF,Alveolar Rhabdomyosarcoma,alveolar rhabdomyosarcoma,Sarcoma,Rhabdomyosarcoma: alveolar,Alveolar Rhabdomyosarcoma (C3749),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,CM
,CCLFPEDS0020T,CCLF_PEDS_0020_T,PEDS187T,Wilms Tumor,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,Pediatric,,,,,,,,,,,,,CM
,CCLFHNSC0001T,CCLF_HNSC_0001_T,SP022T,Squamous cell carcinoma,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,CCLFHNSC0002T,CCLF_HNSC_0002_T,SP025T_P,Squamous cell carcinoma,hnscc,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,AA01T,,AA01T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,2D Adherent,CM
,AA02T,,AA02T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,2D Adherent,CM
,AA13T,,AA13T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,2D Adherent,CM
,AA19T,,AA19T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,AA26T,,AA26T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,AA33T,,AA33T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,AA36T,,AA36T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,AA47T,,AA47T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,AA53T_3,,AA53T_3,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,AB001T_ASC,,AB001T_ASC,,gastric adenocarcinoma,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,2D Adherent,CM
,AB006T_P,,AB006T_P,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,2D Adherent,CM
,AB019T_LN1,,AB019T_LN1,,gastric adenocarcinoma,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,AB035T_PDX,,AB035T_PDX,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Pleural Cavity,Unknown,,,,,,,,,,,,,3D,CM
,BT1016,,BT1016,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,CM
,BT628,,BT628,,meningioma,Brain Cancer,Meningioma,Meningioma (C3230),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,BT684,,BT684,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,BT857,,BT857,,glioma low grade,Brain Cancer,Glioma,Glioma (C3059),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,CM
,BT907,,BT907,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,RETM
,BT952,,BT952,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,CM
,BT961,,BT961,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,CM
,CCLF_AA1074T,,CCLF_AA1074T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1103T_ASC,,CCLF_AA1103T_ASC,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1104T,,CCLF_AA1104T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1106T,,CCLF_AA1106T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1111T,,CCLF_AA1111T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1114T,,CCLF_AA1114T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1116T,,CCLF_AA1116T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1118T,,CCLF_AA1118T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1122T_ASC,,CCLF_AA1122T_ASC,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1128T_ASC,,CCLF_AA1128T_ASC,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1129T_ASC,,CCLF_AA1129T_ASC,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1130T_ASC,,CCLF_AA1130T_ASC,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1131T,,CCLF_AA1131T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Omentum,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1137T,,CCLF_AA1137T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1139T,,CCLF_AA1139T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Omentum,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AA1144T,,CCLF_AA1144T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1067T,,CCLF_AB1067T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1070T_ASC,,CCLF_AB1070T_ASC,,esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1079T,,CCLF_AB1079T,,esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1080T,,CCLF_AB1080T,,esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1083T_PF,,CCLF_AB1083T_PF,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1086T_ASC,,CCLF_AB1086T_ASC,,esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1090T,,CCLF_AB1090T,,esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1091T,,CCLF_AB1091T,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1092T,,CCLF_AB1092T,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1094T,,CCLF_AB1094T,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Liver,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1097T_ASC,,CCLF_AB1097T_ASC,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1098T,,CCLF_AB1098T,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_AB1100T,,CCLF_AB1100T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1006T,,CCLF_CRCRF1006T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1015T,,CCLF_CRCRF1015T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1016T,,CCLF_CRCRF1016T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1017T,,CCLF_CRCRF1017T,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1018T,,CCLF_CRCRF1018T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_CRCRF1020T,,CCLF_CRCRF1020T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1031T,,CCLF_CRCRF1031T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1036T,,CCLF_CRCRF1036T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1042T,,CCLF_CRCRF1042T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1047T,,CCLF_CRCRF1047T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1054T,,CCLF_CRCRF1054T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1055T,,CCLF_CRCRF1055T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CRCRF1066T,,CCLF_CRCRF1066T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_CY1002T,,CCLF_CY1002T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_JL1003T,,CCLF_JL1003T,,thyroid cancer,Thyroid Cancer,Unknown,Thyroid Gland Carcinoma (C4815),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLF_KL1017T,,CCLF_KL1017T,,spindle cell sarcoma,Sarcoma,Spindle Cell Sarcoma,Sarcoma (C9118),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,CM
,CCLF_KL1051T,,CCLF_KL1051T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLF_KL1060T,,CCLF_KL1060T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,Neurosphere (NSA)
,CCLF_KL1066T,,CCLF_KL1066T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,Neurosphere (NSA)
,CCLF_KL1077T,,CCLF_KL1077T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLF_KL1092T,,CCLF_KL1092T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,CM
,CCLF_KL1095T,,CCLF_KL1095T,,anaplastic astrocytoma,Brain Cancer,Astrocytoma: anaplastic,Anaplastic Astrocytoma (C9477),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLF_KL1115T,,CCLF_KL1115T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Neurosphere (NSA)
,CCLF_KL1129T,,CCLF_KL1129T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,,Neurosphere (NSA)
,CCLF_KL1131T,,CCLF_KL1131T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLF_KL1160T,,CCLF_KL1160T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,Neurosphere (NSA)
,CCLF_KL1185T,,CCLF_KL1185T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_KL1187T,,CCLF_KL1187T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_KL1194T,,CCLF_KL1194T,,meningioma,Brain Cancer,Meningioma,Meningioma (C3230),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_KL1197T,,CCLF_KL1197T,,lung adenocarcinoma,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,3D,CM
,CCLF_KL1198T,,CCLF_KL1198T,,lung cancer,Lung Cancer,Unknown,Lung Carcinoma (C4878),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,3D,CM
,CCLF_KL1201T,,CCLF_KL1201T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,Neurosphere (NSA)
,CCLF_KL1204T,,CCLF_KL1204T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,Neurosphere (NSA)
,CCLF_KL1207T,,CCLF_KL1207T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,Neurosphere (NSA)
,CCLF_KL1209T,,CCLF_KL1209T,,glioblastoma multiforme,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Suspension,Neurosphere (NSA)
,CCLF_KL1212T,,CCLF_KL1212T,,meningioma,Brain Cancer,Meningioma,Meningioma (C3230),Primary,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Neurosphere (NSA)
,CCLF_KL1217T,,CCLF_KL1217T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_KL1230T,,CCLF_KL1230T,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLF_KL1272T,,CCLF_KL1272T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Central Nervous System,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_NH1002T,,CCLF_NH1002T,,colon adenocarcinoma,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Sample Derivation,CCLF,Colon,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,CCLF_NH1003T,,CCLF_NH1003T,,colon adenocarcinoma,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Sample Derivation,CCLF,Colon,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,CCLF_NH1005T,,CCLF_NH1005T,,colon adenocarcinoma,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Sample Derivation,CCLF,Colon,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_NH1006T,,CCLF_NH1006T,,colon adenocarcinoma,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Sample Derivation,CCLF,Colon,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_PEDS1011T,,CCLF_PEDS1011T,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,Pediatric,,,,,,,,Test,,,,2D Adherent,CM
,CCLF_PEDS1064T,,CCLF_PEDS1064T,,alveolar rhabdomyosarcoma,Sarcoma,Rhabdomyosarcoma: alveolar,Alveolar Rhabdomyosarcoma (C3749),Primary,Sample Derivation,CCLF,Soft Tissue,Unknown,Pediatric,,,,,,,,,,,,2D Adherent,Ar5
,CCLF_PEDS1065T,,CCLF_PEDS1065T,,congenital/infantile rhabdomyosarcoma,Sarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma (C3359),Primary,Sample Derivation,CCLF,Soft Tissue,Unknown,Pediatric,,,,,,,,Test,,,,2D Adherent,CM
,CCLF_PEDS1113T,,CCLF_PEDS1113T,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,,,,,,,,,,,,,2D Adherent,CM
,CCLF_RCRF1050T,,CCLF_RCRF1050T,,esophageal carcinoma,Esophageal Cancer,Carcinoma,Esophageal Carcinoma (C3513),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CCLF_RCRF1053T,,CCLF_RCRF1053T,,stomach adenocarcinoma,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Ascites,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CO002T_1,,CO002T_1,,esophageal adenocarcinoma,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Sample Derivation,CCLF,Esophagus,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,CO005T,,CO005T,,gastric adenocarcinoma,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CO006T_1 P1,,CO006T_1 P1,,gastric adenocarcinoma,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Sample Derivation,CCLF,Stomach,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CO007T,,CO007T,,gastric adenocarcinoma,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,COL007T,,COL007T,,colorectal cancer,Colon/Colorectal Cancer,Colorectal Carcinoma,Colorectal Carcinoma (C2955),Primary,Sample Derivation,CCLF,Colon,Unknown,,,,,,,,,,,,,,F Media
,COL016T,,COL016T,,colorectal adenocarcinoma,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Primary,Sample Derivation,CCLF,Colon,Unknown,,,,,,,,,,,,,3D,Pancreas Organoid
,CY005T,,CY005T,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,2D Adherent,Ar5
,CY025T_1,,CY025T_1,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,2D Adherent,RETM
,CY025T_2,,CY025T_2,,melanoma,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Sample Derivation,CCLF,Lymph Node,Unknown,,,,,,,,,,,,,2D Adherent,RETM
,DW019T,,DW019T,,double-hit diffuse large b cell lymphoma,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Sample Derivation,CCLF,Bone Marrow,Unknown,,,,,,,,,,,,,,Ar5
,DW020T,,DW020T,,double-hit diffuse large b cell lymphoma,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Sample Derivation,CCLF,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,,,,,Ar5
,DW036T,,DW036T,,t-pll,Leukemia,T-Cell Prolymphocytic Leukemia,T-Cell Prolymphocytic Leukemia (C4752),Primary,Sample Derivation,CCLF,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,,,,,Ar5
,DW038T,,DW038T,,ptcl-nos,Lymphoma,Peripheral T-cell,Peripheral T-Cell Lymphoma: Not Otherwise Specified (C4340),Unknown,Sample Derivation,CCLF,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,,,,,Ar5
,DW048T,,DW048T,,t-pll,Leukemia,T-Cell Prolymphocytic Leukemia,T-Cell Prolymphocytic Leukemia (C4752),Primary,Sample Derivation,CCLF,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,,,,,Ar5
,EW010T,,EW010T,,liposarcoma,Liposarcoma,Unknown,Liposarcoma (C3194),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,
,HG001T,,HG001T,,squamous cell carcinoma,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Sample Derivation,CCLF,Head and Neck,Unknown,,,,,,,,,,,,,,CM
,HG002T,,HG002T,,squamous cell carcinoma,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Sample Derivation,CCLF,Head and Neck,Unknown,,,,,,,,,,,,,,
,HG011T,,HG011T,,sarcoma,Sarcoma,Unknown,Sarcoma (C9118),Primary,Sample Derivation,CCLF,Soft Tissue,Unknown,,,,,,,,,,,,,,
,HG017T_2,,HG017T_2,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,,CM
,HG018T,,HG018T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,,CM
,HG018T_2,,HG018T_2,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,Pancreas Organoid
,HG019T,,HG019T,,pancreatic adenocarcinoma,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Sample Derivation,CCLF,Pancreas,Unknown,,,,,,,,,,,,,,
,JL49T_PF,,JL49T_PF,,papillary thyroid carcinoma,Thyroid Cancer,Carcinoma: papillary,Thyroid Gland Papillary Carcinoma (C4035),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,,CM
,JL50T_PF2,,JL50T_PF2,,papillary thyroid carcinoma,Thyroid Cancer,Carcinoma: papillary,Thyroid Gland Papillary Carcinoma (C4035),Metastasis,Sample Derivation,CCLF,Pleural Effusion,Unknown,,,,,,,,,,,,,,CM
,JL56T,,JL56T,,medullary thyroid cancer,Thyroid Cancer,Medullary,Thyroid Gland Medullary Carcinoma (C3879),Metastasis,Sample Derivation,CCLF,Pleural Cavity,Unknown,,,,,,,,,,,,,,RETM
,PEDS005T_PF_AD,,PEDS005T_PF_AD,,renal medullary carcinoma,Kidney Cancer,Renal Medullary Carcinoma,Kidney Medullary Carcinoma (C7572),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,PEDS005T_PF_SUS,,PEDS005T_PF_SUS,,renal medullary carcinoma,Kidney Cancer,Renal Medullary Carcinoma,Kidney Medullary Carcinoma (C7572),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,PEDS012T_P,,PEDS012T_P,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,PEDS022T,,PEDS022T,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,PEDS040T,,PEDS040T,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Unknown,Sample Derivation,CCLF,Unknown,Unknown,Pediatric,,,,,,,,,,,,,CM
,PEDS051T,,PEDS051T,,alveolar rhabdomyosarcoma,Sarcoma,Rhabdomyosarcoma: alveolar,Alveolar Rhabdomyosarcoma (C3749),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,PEDS063T,,PEDS063T,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,,,,,,,,,,,,,2D Adherent,CM
,PEDS078T,,PEDS078T,,ewing sarcoma,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Unknown,Sample Derivation,CCLF,Unknown,Unknown,,,,,,,,,,,,,,CM
,PEDS109T_AT,,PEDS109T_AT,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,,,,,,,,,,,,,,CM
,PEDS118T,,PEDS118T,,angiosarcoma,Sarcoma,Angiosarcoma,Angiosarcoma (C3088),Primary,Sample Derivation,CCLF,Pericardial Cavity,Unknown,Pediatric,,,,,,,,,,,,,Ar5
,PEDS127T_AT2,,PEDS127T_AT2,,yolk sac tumor,Embryonal Cancer,Unknown,Embryonal Carcinoma (C3752,Metastasis,Sample Derivation,CCLF,Liver,Unknown,Pediatric,,,,,,,,,,,,,CM
,PEDS145T_PDX,,PEDS145T_PDX,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,,,,,,,,,,,,,,CM
,PEDS160T,,PEDS160T,,wilms tumor,Kidney Cancer,Wilms Tumor,Kidney Wilms Tumor (C40407),Primary,Sample Derivation,CCLF,Kidney,Unknown,Pediatric,,,,,,,,,,,,,CM
,PM860,,PM860,,colorectal adenocarcinoma,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Metastasis,Sample Derivation,CCLF,Peritoneal Cavity,Unknown,,,,,,,,,Test,,,,,Pancreas Organoid
ACH-000001,NIHOVCAR3,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,60,,,,,,,,,,Female,,,,RPMI + 20% FBS + 0.01mg/ml Insulin (Bovine)
ACH-000002,HL60,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M3 (Promyelocytic),Acute Promyelocytic Leukemia with PML-RARA (C3182),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,35,Pediatric,,,,,,,,,Female,,,2D Suspension,IMDM + 10% FBS
ACH-000004,HEL,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M6 (Erythroleukemia),Acute Erythroid Leukemia (C8923),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,30,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000005,HEL9217,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M6 (Erythroleukemia),Acute Erythroid Leukemia (C8923),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,30,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000006,MONOMAC6,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Monocytic),Acute Monocytic Leukemia (C4861),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,64,Pediatric,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000007,LS513,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Large Intestine,63,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000009,C2BBE1,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,72,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS + Glutamine + Insulin-Transferrin-Selenium
ACH-000011,253J,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,53,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000012,HCC827,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,39,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000013,ONCODG1,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,60,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000014,HS294T,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,56,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000014,HS294T,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,56,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000015,NCIH1581,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Primary,Cell Line Onboarding,Vendor,Lung,44,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 5% FBS
ACH-000017,SKBR3,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,43,,,,,,,,,,Female,,,2D Mixed adherent and suspension,McCoy's 5A + 10% FBS
ACH-000018,T24,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Primary,Cell Line Onboarding,Vendor,Urinary Tract,81,,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000019,MCF7,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,69,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS + 0.01mg/ml Insulin (Bovine)
ACH-000020,MHHCALL2,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,15,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000021,NCIH1693,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,55,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000022,PATU8988S,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,64,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM Glutamax
ACH-000023,PATU8988T,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,64,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000023,PATU8988T,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,64,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000024,OPM2,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,56,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000026,253JBV,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,53,,,,,,,,,,Male,,,2D Mixed adherent and suspension,DMEM + 10% FBS
ACH-000027,GOS3,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,55,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000028,KPL1,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000030,PC14,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000031,PANC0213,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,64,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000032,MHHCALL3,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,11,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 20% FBS
ACH-000035,NCIH1650,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,27,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000037,S117,,,,,Sarcoma,Unknown,Sarcoma (C9118),Unknown,Cell Line Onboarding,Vendor,Soft Tissue,47,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000038,EHEB,,,,,Leukemia,Chronic Lymphoblastic Leukemia (CLL): B-cell,Chronic Lymphocytic Leukemia (C3163),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,69,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% heat inactivated FBS
ACH-000039,SKNMC,,,,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Metastasis,Cell Line Onboarding,Vendor,Bone,14,Pediatric,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000040,U118MG,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000042,PANC0203,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,70,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS + 1mM Sodium pyruvate
ACH-000043,HS895T,,,,,Fibroblast,Malignant melanoma,Fibroblast,Metastasis,Cell Line Onboarding,Vendor,Fibroblast,48,,,,,,,,,,Female,,,,
ACH-000044,MDAMB134VI,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,47,,,,,,,,,,Female,,,,
ACH-000045,MV411,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,10,Pediatric,,,,,,,,,Male,,,2D Suspension,IMDM + 10% FBS
ACH-000046,ACHN,,,,,Kidney Cancer,Renal Cell Adenocarcinoma,Renal Cell Carcinoma (C9385),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,22,,,,,,,,,,Male,,,,MEM + 10% FBS
ACH-000047,GCIY,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 15% FBS
ACH-000048,TOV112D,,,,,Ovarian Cancer,Adenocarcinoma: endometrioid,Ovarian Endometrioid Adenocarcinoma (C7979),Primary,Cell Line Onboarding,Vendor,Ovary,42,,,,,,,,,,Female,,,2D Adherent,MCDB 105:Medium 199 (1:1) + 15% FBS + 1.5g/l Sodium bicarbonate
ACH-000050,NCIH929,,,,,Myeloma,Multiple Myeloma: plasmacytoma,Plasmacytoma (C9349),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,62,,,,,,,,,,Female,,,,
ACH-000051,TE617T,,,,,Sarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma (C3359),Primary,Cell Line Onboarding,Vendor,Soft Tissue,1.67,Pediatric,,,,,,,,,Female,,,,DMEM + 10% FBS
ACH-000054,HT1080,,,,,Sarcoma,Fibrosarcoma,Fibrosarcoma (C3043),Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,35,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000055,D283MED,,,,,Brain Cancer,Medulloblastoma,Medulloblastoma (C3222),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,6,Pediatric,,,,,,,,,Male,,,2D Mixed adherent and suspension,MEM + 10% FBS
ACH-000056,DOHH2,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,60,,,,,,,,,,Male,,,,
ACH-000058,ML1,,,,,Thyroid Cancer,Carcinoma: follicular,Thyroid Gland Follicular Carcinoma (C8054),Unknown,Cell Line Onboarding,Vendor,thyroid,Unknown,,,,,,,,,,Unknown,,,2D Adherent,DMEM + 20% FBS
ACH-000059,SUPB15,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Primary,Cell Line Onboarding,Vendor,Bone Marrow,9,Pediatric,,,,,,,,,Male,,,,
ACH-000060,PANC1005,,,,,Pancreatic Cancer,Carcinoma,Pancreatic Carcinoma (C3850),Primary,Cell Line Onboarding,Vendor,Pancreas,56,,,,,,,,,,Male,,,2D Adherent,RPMI + 15% FBS + 2mM Glutamine + 1mM Sodium pyruvate + 60ug/ml Insulin + 10mM HEPES + 1.5g/l Sodium bicarbonate + 4.5g/l Glucose
ACH-000061,HH,,,,,Lymphoma,T-cell: Non-Hodgkins: Cutaneous,Cutaneous T-Cell Non-Hodgkin Lymphoma (C3467),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,61,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000062,RERFLCMS,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-000063,HS616T,,,,,Fibroblast,B-Cell: Hodgkins Lymphoma,Fibroblast,Unknown,Cell Line Onboarding,Unknown,Fibroblast,16,,,,,,,,,,Male,,,,
ACH-000065,OCIAML5,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,77,Pediatric,,,,,,,,,Male,,,2D Suspension,AlphaMEM + 20% FBS
ACH-000066,HCC4006,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,,
ACH-000067,HS683,,,,,Brain Cancer,Oligodendroglioma,Oligodendroglioma (C3288),Primary,Cell Line Onboarding,Vendor,Central Nervous System,76,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000068,REC1,,,,,Lymphoma,B-cell: Non-Hodgkins: Mantle Cell,Mantle Cell Lymphoma (C4337),Unknown,Cell Line Onboarding,Vendor,Lymph Node,61,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000069,HS611T,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,48,,,,,,,,,,Female,,,2D Suspension,DMEM + 10% FBS
ACH-000070,697,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Primary,Cell Line Onboarding,Vendor,Bone Marrow,12,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 20% heat inactivated FBS
ACH-000071,HS706T,,,,,Fibroblast,Giant cell tumor,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,16,,,,,,,,,,Female,,,,
ACH-000072,MEG01,,,,,Leukemia,Chronic Myelogenous Leukemia (CML),Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C3174),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,55,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000073,GRANTA519,,,,,Lymphoma,B-cell: Non-Hodgkins: Mantle Cell,Mantle Cell Lymphoma (C4337),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,58,,,,,,,,,,Female,,,2D Suspension,DMEM + 10% FBS + 2mM Glutamax
ACH-000074,KU812,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,38,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000075,U87MG,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Primary,Cell Line Onboarding,Vendor,Central Nervous System,44,,,,,,,,,,Unknown,,,2D Adherent,MEM + 10% FBS
ACH-000076,NCO2,,,,,Leukemia,Chronic Myelogenous Leukemia (CML),Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C3174),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,35,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000077,MJ,,,,,Lymphoma,T-cell: Non-Hodgkins: Cutaneous,Cutaneous T-Cell Non-Hodgkin Lymphoma (C3467),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,50,,,,,,,,,,Male,,,,IMDM + 10% FBS
ACH-000078,MHHNB11,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Autonomic Ganglia,4,Pediatric,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000079,TE125T,,,,,Fibroblast,Rhabdomyosarcoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,1,Pediatric,,,,,,,,,Female,,,,MEM + 10% FBS
ACH-000080,BDCM,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Eosinophilic),Acute Myelomonocytic Leukemia with Abnormal Eosinophils (C9020),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000081,GDM1,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,66,Pediatric,,,,,,,,,Female,,,,
ACH-000082,G292CLONEA141B1,,,,,Bone Cancer,Osteosarcoma,Osteosarcoma (C9145),Primary,Cell Line Onboarding,Vendor,Bone,9,Pediatric,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000083,HS281T,,,,,Fibroblast,Breast,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,37,,,,,,,,,,Female,,,,
ACH-000084,MUTZ3,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,29,,,,,,,,,,Male,,,2D Adherent,AlphaMEM + 20% heat inactivated FBS + Purified cytokine
ACH-000085,T3M4,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Lymph Node,64,,,,,,,,,,Male,,,2D Adherent,F12 + 10% FBS
ACH-000086,ACCMESO1,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Unknown,Cell Line Onboarding,Vendor,Pleura,61,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS + Glutamax + Sodium pyruvate
ACH-000088,HS172T,,,,,Fibroblast,Urinary tract,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,50,,,,,,,,,,Male,,,,
ACH-000089,NCIH684,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Liver,55,Pediatric,,,,,,,,,Male,,,,ACL4
ACH-000090,PC3,,,,,Prostate Cancer,Adenocarcinoma,Prostate Adenocarcinoma (C2919),Metastasis,Cell Line Onboarding,Vendor,Bone,62,,,,,,,,,,Male,,,2D Adherent,F12 + 10% FBS
ACH-000091,OV56,,,,,Ovarian Cancer,Carcinoma: serous,Ovarian Carcinoma (C4908),Metastasis,Cell Line Onboarding,Vendor,ascites,46,,,,,,,,,,Female,,,,
ACH-000092,NCIH2452,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Metastasis,Cell Line Onboarding,Vendor,Pleura,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000093,PANC0504,,,,,Pancreatic Cancer,Carcinoma,Pancreatic Carcinoma (C3850),Primary,Cell Line Onboarding,Vendor,Pancreas,77,,,,,,,,,,Female,,,2D Adherent,RPMI + 15% FBS + 20units/ml Insulin
ACH-000094,HPAFII,,,,,Pancreatic Cancer,Carcinoma,Pancreatic Carcinoma (C3850),Metastasis,Cell Line Onboarding,Vendor,ascites,44,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000095,D341,,,,,Brain Cancer,Medulloblastoma,Medulloblastoma (C3222),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,3.5,Pediatric,,,,,,,,,Male,,,2D Mixed adherent and suspension,DMEM:F12 (1:1) + 15% FBS
ACH-000096,G401,,,,,Rhabdoid,Malignant Rhabdoid Tumor,Atypical Teratoid/Rhabdoid Tumor (C6906),Primary,Cell Line Onboarding,Vendor,Kidney,0.25,Pediatric,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000096,G401,,,,,Rhabdoid,Malignant Rhabdoid Tumor,Atypical Teratoid/Rhabdoid Tumor (C6906),Primary,Cell Line Onboarding,Vendor,Kidney,0.25,Pediatric,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000097,ZR751,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,ascites,63,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000098,GAMG,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,42,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM Glutamax
ACH-000099,SIMA,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Unknown,Cell Line Onboarding,Vendor,Autonomic Ganglia,1.6666,Pediatric,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000100,RH41,,,,,Sarcoma,Rhabdomyosarcoma: alveolar,Alveolar Rhabdomyosarcoma (C3749),Metastasis,Cell Line Onboarding,Vendor,Liver,Unknown,Pediatric,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000101,KE37,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,27,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000102,GMS10,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,49,,,,,,,,,,Male,,,,AlphaMEM + 10% FBS
ACH-000103,CAOV4,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,Ovary,45,,,,,,,,,,Female,,,2D Adherent,RPMI + 20% FBS
ACH-000104,LOUCY,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,38,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000105,ALLSIL,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,17,Pediatric,,,,,,,,,Male,,,,
ACH-000106,JVM2,,,,,Leukemia,Chronic Lymphoblastic Leukemia (CLL): B-cell,Chronic Lymphocytic Leukemia (C3163),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,63,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000107,CAPAN2,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,56,,,,,,,,,,Male,,,,McCoy's 5A + 10% FBS
ACH-000108,KP3,,,,,Pancreatic Cancer,Ductal Adenosquamous Carcinoma: exocrine,Pancreatic Carcinoma (C3850),Metastasis,Cell Line Onboarding,Vendor,Liver,75,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000109,NCIH3255,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Academic lab,Lung,Unknown,,,,,,,,,,Female,,,2D Mixed adherent and suspension,ACL4 + 10% FBS
ACH-000110,NCCSTCK140,,,,,Gastric Cancer,Carcinoma,Gastric Carcinoma (C4911),Unknown,Cell Line Onboarding,Vendor,stomach,36,,,,,,,,,,Female,,,2D Suspension,DMEM + 10% FBS
ACH-000111,HCC1187,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,41,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000112,SIGM5,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Monocytic),Acute Monocytic Leukemia (C4861),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,63,Pediatric,,,,,,,,,Male,,,2D Suspension,IMDM + 10% FBS
ACH-000113,OCIAML2,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M4 (Myelomonocytic),Acute Myelomonocytic Leukemia (C7463),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,65,,,,,,,,,,Male,,,2D Suspension,AlphaMEM + 20% FBS
ACH-000114,SU8686,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,57,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000114,SU8686,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,57,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000115,VCAP,,,,,Prostate Cancer,Adenocarcinoma,Prostate Adenocarcinoma (C2919),Metastasis,Cell Line Onboarding,Vendor,Bone,59,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000116,OAW28,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000117,EFM192A,,,,,Breast Cancer,Adenocarcinoma,Breast Adenocarcinoma (C5214),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,46,,,,,,,,,,Female,,,,
ACH-000118,HUPT3,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,ascites,66,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000119,HS863T,,,,,Fibroblast,Ewings Sarcoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,5,Pediatric,,,,,,,,,Female,,,,
ACH-000120,CHP212,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,Pediatric,,,,,,,,,Male,,,2D Adherent,MEM:F12 (1:1) + 10% FBS
ACH-000121,NCIH2405,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,ascites,47,,,,,,,,,,Male,,,2D Mixed adherent and suspension,ACL4
ACH-000122,SUPT11,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,74,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000123,COV434,,,,,Ovarian Cancer,Adenocarcinoma: endometrioid,Ovarian Endometrioid Adenocarcinoma (C7979),Primary,Cell Line Onboarding,Vendor,Ovary,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM L-glutamine
ACH-000124,OCILY19,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Cell Line Onboarding,Vendor,Bone Marrow,27,,,,,,,,,,Female,,,2D Suspension,AlphaMEM + 10% FBS
ACH-000125,TO175T,,,,,Fibroblast,B-Cell: Hodgkins Lymphoma,Fibroblast,Metastasis,Cell Line Onboarding,Vendor,Lymph Node,29,,,,,,,,,,Male,,,,
ACH-000126,KG1C,,,,,Brain Cancer,Oligodendroglioma,Oligodendroglioma (C3288),Primary,Cell Line Onboarding,Vendor,Central Nervous System,13,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000129,NCIH1341,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Cervix,Unknown,,,,,,,,,,Female,,,,
ACH-000130,NALM19,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,26,,,,,,,,,,Male,,,,
ACH-000131,HS229T,,,,,Fibroblast,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,65,,,,,,,,,,Male,,,,
ACH-000132,JHOS2,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Primary,Cell Line Onboarding,Vendor,Ovary,45,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS
ACH-000133,HS729,,,,,Fibroblast,Rhabdomyosarcoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,74,,,,,,,,,,Male,,,2D Adherent,DMEM + 5% FBS
ACH-000134,HS274T,,,,,Fibroblast,Breast carcinoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,66,,,,,,,,,,Female,,,,
ACH-000135,HS940T,,,,,Fibroblast,Melanoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,57,,,,,,,,,,Male,,,,
ACH-000136,CHP126,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Primary,Cell Line Onboarding,Vendor,Autonomic Ganglia,1.166666667,Pediatric,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000137,8MGBA,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,54,,,,,,,,,,Female,,,2D Adherent,MEM + 20% FBS
ACH-000138,CFPAC1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,26,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000139,PANC0327,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,65,,,,,,,,,,Female,,,2D Adherent,RPMI + 15% FBS + 0.1unit/ml Insulin
ACH-000140,PFEIFFER,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,,
ACH-000141,SNU308,,,,,Gallbladder Cancer,Adenocarcinoma,Gallbladder Adenocarcinoma (C9166),Unknown,Cell Line Onboarding,Vendor,Biliary Tract,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS + Sodium bicarbonate
ACH-000142,CAL29,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,80,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000144,RERFGC1B,,,,,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,41,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000146,THP1,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Monocytic),Acute Monocytic Leukemia (C4861),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,1,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS + 0.5mM BME
ACH-000147,T47D,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,54,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS + 2ug/ml Insulin
ACH-000147,T47D,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,54,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS + 2ug/ml Insulin
ACH-000148,HS578T,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Primary,Cell Line Onboarding,Vendor,Breast,74,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000149,SKNSH,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,4,Pediatric,,,,,,,,,Female,,,,MEM + 10% FBS
ACH-000150,HCC2935,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Pleural Effusion,39,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000151,JM1,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Male,,,2D Suspension,IMDM + 10% FBS
ACH-000152,M059K,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,33,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS
ACH-000153,NCIH2052,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,65,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000154,HS888T,,,,,Fibroblast,Osteosarcoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,20,Pediatric,,,,,,,,,Male,,,,
ACH-000155,SW1990,,,,,Pancreatic Cancer,Ductal Adenocarcinoma,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Spleen,56,,,,,,,,,,Male,,,,L15 + 10% FBS
ACH-000156,MHHCALL4,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,10,Pediatric,,,,,,,,,Male,,,2D Adherent,RPMI + 20% FBS
ACH-000157,A4FUK,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Cell Line Onboarding,Vendor,ascites,52,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000158,OCILY3,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Cell Line Onboarding,Academic lab,Bone Marrow,Unknown,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS + 2mM L-glutamine + 1mM Sodium pyruvate + 10mM HEPES
ACH-000159,OSRC2,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000161,CORL105,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000162,GA10,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,41,,,,,,,,,,Male,,,,
ACH-000163,SW579,,,,,Thyroid Cancer,Squamous Cell Carcinoma,Thyroid Gland Squamous Cell Carcinoma (C46008),Primary,Cell Line Onboarding,Vendor,thyroid,59,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000164,PANC1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000165,HS751T,,,,,Fibroblast,Lymphoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,Unknown,,,,,,,,,,Male,,,,
ACH-000166,KASUMI6,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M2 (Myeloblastic),Acute Myeloid Leukemia with Maturation (C3250),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,64,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000167,KE97,,,,,Gastric Cancer,Adenocarcinoma: mucinous,Mucinous Gastric Adenocarcinoma (C5248),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,52,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000168,NOMO1,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Monocytic),Acute Monocytic Leukemia (C4861),Primary,Cell Line Onboarding,Vendor,Bone Marrow,31,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000171,VMRCRCZ,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Unknown,,,,
ACH-000173,JHUEM3,,,,,Endometrial/Uterine Cancer,Unknown,Endometrial Carcinoma (C7558),Unknown,Cell Line Onboarding,Vendor,Endometrium,Unknown,,,,,,,,,,Female,,,,DMEM:F12 (1:1) + 10% FBS + NEAA
ACH-000174,CAL62,,,,,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Primary,Cell Line Onboarding,Vendor,Pleural Effusion,70,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000175,TE159T,,,,,Fibroblast,Rhabdomyosarcoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,6,Pediatric,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000176,LOUNH91,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,64,,,,,,,,,,Female,,,,RPMI + 20% FBS + 2mM Glutamax
ACH-000177,NCIH660,,,,,Prostate Cancer,Small Cell Carcinoma,Prostate Small Cell Carcinoma (C6766),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,63,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 30nM Selenium + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000178,HS766T,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,46,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000179,NCIH1618,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,55,,,,,,,,,,Female,,,,
ACH-000180,HS839T,,,,,Fibroblast,Melanoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,42,,,,,,,,,,Female,,,,
ACH-000181,SCC9,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,25,,,,,,,,,,Male,,,,
ACH-000182,SNU869,,,,,Bile Duct Cancer,Cholangiocarcinoma: extrahepatic: ampullary,Ampulla of Vater Adenocarcinoma (C6650),Unknown,Cell Line Onboarding,Vendor,Biliary Tract,Unknown,,,,,,,,,,Unknown,,,2D Mixed adherent and suspension,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000183,L363,,,,,Leukemia,Plasma Cell,Plasma Cell Leukemia (C3180),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,36,,,,,,,,,,Female,,,2D Suspension,RPMI + 15% FBS
ACH-000184,HS343T,,,,,Fibroblast,Breast carcinoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,47,,,,,,,,,,Female,,,,
ACH-000185,HS737T,,,,,Fibroblast,Giant Cell Tumor,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,10,,,,,,,,,,Female,,,,
ACH-000186,NCIH2444,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): unspecified,Non-Small Cell Lung Carcinoma (C2926),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-000187,CORL311,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,63,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS + 2mM Glutamax
ACH-000188,SCC25,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,70,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + 0.4ug/ml Hydrocortisone
ACH-000189,RCC10RGB,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000190,HDMYZ,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,29,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS
ACH-000191,BHT101,,,,,Thyroid Cancer,Carcinoma: papillary,Thyroid Gland Papillary Carcinoma (C4035),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,63,,,,,,,,,,Female,,,2D Adherent,DMEM + 20% FBS
ACH-000192,MFE280,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,77,,,,,,,,,,Female,,,2D Adherent,RPMI:MEM(1:1) + 20% FBS + 2mM L-glutamine + 1x Insulin-Transferrin-Selenium
ACH-000193,KARPAS620,,,,,Leukemia,Plasma Cell,Plasma Cell Leukemia (C3180),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,77,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000194,HS934T,,,,,Fibroblast,Melanoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,58,,,,,,,,,,Female,,,,
ACH-000195,SET2,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,71,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000196,HCC1599,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,44,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000197,TALL1,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Primary,Cell Line Onboarding,Vendor,Bone Marrow,28,Pediatric,,,,,,,,,Male,,,,
ACH-000198,EOL1,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Eosinophilic),Acute Myelomonocytic Leukemia with Abnormal Eosinophils (C9020),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,33,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000199,HS255T,,,,,Fibroblast,Colorectal,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,46,,,,,,,,,,Female,,,,
ACH-000200,NMCG1,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000201,A204,,,,,Sarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma (C3359),Primary,Cell Line Onboarding,Vendor,Soft Tissue,1,Pediatric,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000201,A204,,,,,Sarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma (C3359),Primary,Cell Line Onboarding,Vendor,Soft Tissue,1,Pediatric,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000202,COLO320,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Large Intestine,55,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000203,NH6,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Autonomic Ganglia,0.75,Pediatric,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000204,LP1,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,56,,,,,,,,,,Female,,,2D Mixed adherent and suspension,IMDM + 10% FBS
ACH-000205,PK59,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000207,DETROIT562,,,,,Head and Neck Cancer,Carcinoma: pharynx,Head and Neck Carcinoma (C35850),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Female,,,,MEM + 10% FBS
ACH-000209,SNU1079,,,,,Bile Duct Cancer,Cholangiocarcinoma: intrahepatic,Intrahepatic Cholangiocarcinoma (C35417),Unknown,Cell Line Onboarding,Vendor,Biliary Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/l L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000210,CADOES1,,,,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,19,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000210,CADOES1,,,,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,19,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000211,DAOY,,,,,Brain Cancer,Primitive Neuroectodermal Tumor (PNET) Medulloblastoma,Peripheral Primitive Neuroectodermal Tumor (C9341),Primary,Cell Line Onboarding,Vendor,Central Nervous System,4,Pediatric,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000212,CAL120,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,43,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000212,CAL120,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,43,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000213,HUPT4,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,ascites,60,,,,,,,,,,Male,,,,AlphaMEM + 10% FBS
ACH-000214,HS675T,,,,,Fibroblast,Colon Carcinoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,Unknown,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000217,JHH6,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,57,,,,,,,,,,Female,,,2D Adherent,William's E Medium + 10% FBS
ACH-000218,PL21,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M3 (Promyelocytic),Acute Promyelocytic Leukemia with PML-RARA (C3182),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,24,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000219,A375,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,54,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000219,A375,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,54,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000220,MINO,,,,,Lymphoma,B-cell: Non-Hodgkins: Mantle Cell,Mantle Cell Lymphoma (C4337),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,64,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000221,SNU398,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,42,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000222,ASPC1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,ascites,62,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000223,HCC1937,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,24,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000224,HS819T,,,,,Fibroblast,Chondrosarcoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,60,Pediatric,,,,,,,,,Male,,,,
ACH-000225,ECC12,,,,,Gastric Cancer,Small Cell Carcinoma,Gastric Small Cell Neuroendocrine Carcinoma (C6764),Unknown,Cell Line Onboarding,Vendor,stomach,63,,,,,,,,,,Male,,,,
ACH-000227,KPNYN,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,2,Pediatric,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000228,BICR31,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000230,HS742T,,,,,Fibroblast,Breast carcinoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,71,,,,,,,,,,Female,,,,
ACH-000231,KALS1,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 5% FBS
ACH-000232,U251MG,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Primary,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000233,DEL,,,,,Lymphoma,T-cell: Non-Hodgkins: Anaplastic Large Cell (ALCL),Anaplastic Large Cell Lymphoma (C3720),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,12,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000234,CAKI2,,,,,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Primary,Cell Line Onboarding,Vendor,Kidney,69,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000235,PANC0403,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,70,,,,,,,,,,Male,,,,RPMI + 15% FBS + 20ug/ml Insulin
ACH-000236,SW1417,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,53,,,,,,,,,,Female,,,2D Suspension,L15 + 10% FBS + Glutamine
ACH-000237,JHOM1,,,,,Ovarian Cancer,Adenocarcinoma: mucinous,Ovarian Mucinous Adenocarcinoma (C5243),Primary,Cell Line Onboarding,Vendor,Ovary,88,,,,,,,,,,Female,,,,DMEM:F12 (1:1) + 10% FBS + 0.1mM NEAA
ACH-000238,SCC4,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,55,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + 0.4ug/ml Hydrocortisone
ACH-000239,HUG1N,,,,,Gastric Cancer,Adenocarcinoma: tubular,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,stomach,55,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000240,HS600T,,,,,Fibroblast,Melanoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,Unknown,,,,,,,,,,Male,,,,
ACH-000241,JK1,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,62,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% heat inactivated FBS
ACH-000242,RT4,,,,,Bladder Cancer,Transitional Cell Papilloma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,63,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000243,DANG,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Cell Line Onboarding,Vendor,Pancreas,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000244,DKMG,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,67,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS + 2mM Glutamine
ACH-000245,BL41,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,8,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000247,OCUM1,,,,,Gastric Cancer,Adenocarcinoma: signet ring cell,Signet Ring Cell Gastric Adenocarcinoma (C5250),Metastasis,Cell Line Onboarding,Vendor,stomach,38,,,,,,,,,,Female,,,2D Mixed adherent and suspension,DMEM + 10% FBS
ACH-000248,AU565,,,,,Breast Cancer,Adenocarcinoma,Breast Adenocarcinoma (C5214),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,43,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000249,CL11,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 20% FBS
ACH-000250,KMRC20,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000252,LS1034,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Large Intestine,54,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000253,COLO201,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Metastasis,Cell Line Onboarding,Vendor,ascites,70,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000254,SCC15,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,55,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + Hydrocortisone
ACH-000255,LMSU,,,,,Gastric Cancer,Unknown,Gastric Carcinoma (C4911),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,27,,,,,,,,,,Female,,,2D Adherent,F12 + 10% FBS
ACH-000256,COV318,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000257,CORL279,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,63,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS + 2mM Glutamine
ACH-000258,DU4475,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Skin,62,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000259,KELLY,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Primary,Cell Line Onboarding,Vendor,Autonomic Ganglia,Unknown,Pediatric,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000260,SKNAS,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,6,Pediatric,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + NEAA
ACH-000261,RERFLCAI,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Unknown,,,2D Adherent,MEM + 10% FBS
ACH-000263,KASUMI1,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M2 (Myeloblastic),Acute Myeloid Leukemia with Maturation (C3250),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,7,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000264,CALU6,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Anaplastic Carcinoma,Non-Small Cell Lung Carcinoma (C2926),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,61,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000265,KP4,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,ascites,50,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS
ACH-000266,SNU213,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Cell Line Onboarding,Vendor,Pancreas,65,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 2mM L-glutamine
ACH-000267,HDLM2,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,74,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000268,SNU245,,,,,Bile Duct Cancer,Cholangiocarcinoma: extrahepatic,Cholangiocarcinoma (C4436),Unknown,Cell Line Onboarding,Vendor,Biliary Tract,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/l L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000269,AM38,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,36,,,,,,,,,,Male,,,2D Adherent,MEM + 20% FBS
ACH-000270,HPAC,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,64,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + 0.002mg/ml Insulin + 5ug/ml Transferrin + 40ng/ml Hydrocortisone + 10ng/ml EGF (do not filter)
ACH-000271,SUDHL10,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,25,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000273,SF539,,,,,Brain Cancer,Glioma,Glioma (C3059),Primary,Cell Line Onboarding,Academic lab,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 5% FBS
ACH-000274,HS852T,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Vendor,Skin,53,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000275,HS834T,,,,,Fibroblast,Melanoma,Fibroblast,Metastasis,Cell Line Onboarding,Unknown,Lymph Node,Unknown,,,,,,,,,,Female,,,,
ACH-000276,HCC38,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,50,,,,,,,,,,Female,,,2D Adherent,Waymouth's MB 752/1 + 10% FBS
ACH-000277,HCC1419,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,42,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000278,COV362,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM L-glutamine
ACH-000280,SNU840,,,,,Ovarian Cancer,Carcinoma: brenner,Ovarian Carcinoma (C4908),Primary,Cell Line Onboarding,Vendor,Ovary,45,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000281,KP2,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,65,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000282,NCIH1755,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Liver,65,,,,,,,,,,Female,,,,
ACH-000284,HS840T,,,,,Fibroblast,Head and neck cancer,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,7,,,,,,,,,,Male,,,,
ACH-000285,TOLEDO,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Female,,,,
ACH-000286,SNU1033,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Large Intestine,45,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000287,NUDUL1,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,43,,,,,,,,,,Male,,,,RPMI + 15% FBS
ACH-000288,BT549,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,72,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% heat inactivated FBS
ACH-000289,SNU466,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,61,,,,,,,,,,Male,,,,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000290,NCIH209,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,55,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000291,OV90,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,64,,,,,,,,,,Female,,,2D Adherent,MCDB 105:Medium 199 (1:1) + 10% FBS + 1.5g/l Sodium bicarbonate
ACH-000292,NCIH841,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lung,51,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + 1ml Insulin-Transferrin-Selenium
ACH-000293,KLE,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,64,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS
ACH-000294,NB4,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M3 (Promyelocytic),Acute Promyelocytic Leukemia with PML-RARA (C3182),Primary,Cell Line Onboarding,Vendor,Bone Marrow,23,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000295,EM2,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,5,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000296,OUMS23,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Pericardial Effusion,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000297,NCIH889,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,69,,,,,,,,,,Female,,,,
ACH-000298,NCIH2029,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,69,,,,,,,,,,Female,,,,
ACH-000301,LAMA84,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,29,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000302,SNU1077,,,,,Endometrial/Uterine Cancer,Mullerian Carcinoma,Malignant Mixed Mesodermal (Mullerian) Tumor (C8975),Primary,Cell Line Onboarding,Vendor,Endometrium,60,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000303,SNU5,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,ascites,33,,,,,,,,,,Female,,,2D Suspension,IMDM + 20% FBS
ACH-000304,WM115,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,59,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000305,ECGI10,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Unknown,Cell Line Onboarding,Vendor,Lymph Node,65,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000306,HS688AT,,,,,Fibroblast,Melanoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,69,,,,,,,,,,Male,,,,
ACH-000307,PK1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000308,EFO21,,,,,Ovarian Cancer,Adenocarcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Metastasis,Cell Line Onboarding,Vendor,ascites,56,,,,,,,,,,Female,,,2D Adherent,RPMI + 20% FBS + 1mM Sodium pyruvate + 0.1mM NEAA
ACH-000309,SKLU1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,60,,,,,,,,,,Female,,,,
ACH-000310,IMR32,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,1,Pediatric,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000311,NCIH2122,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,46,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000312,SKNBE2,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,2.166666667,Pediatric,,,,,,,,,Male,,,2D Adherent,MEM:F12 (1:1) + 10% FBS
ACH-000313,KMRC3,,,,,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000314,HCC2108,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,59,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000315,KARPAS422,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,73,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000316,SNU886,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Unknown,Cell Line Onboarding,Vendor,Liver,57,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000317,TUHR14TKB,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000318,TE10,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000319,MPP89,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,67,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000320,PSN1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 2mM Glutamine
ACH-000321,MOLM6,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,44,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000322,HT144,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,29,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000323,42MGBA,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Primary,Cell Line Onboarding,Vendor,Central Nervous System,63,,,,,,,,,,Male,,,2D Adherent,RPMI:MEM (1:1) + 20% FBS
ACH-000324,JHOC5,,,,,Ovarian Cancer,Carcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Primary,Cell Line Onboarding,Vendor,Ovary,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + 0.1mM NEAA
ACH-000325,SNU620,,,,,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,ascites,59,,,,,,,,,,Female,,,,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000326,JURLMK1,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,73,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000327,NCIH1395,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,55,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000329,CCFSTTG1,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Primary,Cell Line Onboarding,Vendor,Central Nervous System,68,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000330,EFM19,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000331,ISTMES2,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,71,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS + 2mM L-glutamine + NEAA
ACH-000332,YAPC,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,ascites,43,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000333,JHOM2B,,,,,Ovarian Cancer,Adenocarcinoma: mucinous,Ovarian Mucinous Adenocarcinoma (C5243),Primary,Cell Line Onboarding,Vendor,Ovary,Unknown,,,,,,,,,,Female,,,,
ACH-000334,DB,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,ascites,45,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000335,MSTO211H,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,62,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000336,OCIAML3,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M4 (Myelomonocytic),Acute Myelomonocytic Leukemia (C7463),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,57,,,,,,,,,,Male,,,2D Suspension,AlphaMEM + 20% FBS
ACH-000340,HS870T,,,,,Fibroblast,Osteosarcoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,Unknown,Pediatric,,,,,,,,,Male,,,,
ACH-000341,SKNFI,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,11,Pediatric,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS + NEAA
ACH-000342,CL14,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Unknown,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 20% FBS
ACH-000343,NCIH522,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,60,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000344,SNU668,,,,,Gastric Cancer,Adenocarcinoma: signet ring cell,Signet Ring Cell Gastric Adenocarcinoma (C5250),Metastasis,Cell Line Onboarding,Vendor,ascites,63,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/l L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000345,KPNRTBM1,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,Unknown,Pediatric,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000346,JVM3,,,,,Leukemia,Chronic Lymphoblastic Leukemia (CLL): B-cell,Chronic Lymphocytic Leukemia (C3163),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,73,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000347,QGP1,,,,,Pancreatic Cancer,Somatostatinoma,Malignant Somatostatinoma (C65190),Primary,Cell Line Onboarding,Vendor,Pancreas,61,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000348,RPMI7951,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,18,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000349,HCC1500,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,32,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000350,COLO678,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,69,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000351,MKN1,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,72,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000352,HCC1428,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,49,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000353,TE15,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000354,CAPAN1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,40,,,,,,,,,,Male,,,,IMDM + 20% FBS
ACH-000355,NCIH82,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,41,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000356,MKN45,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Liver,62,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000357,JEKO1,,,,,Lymphoma,B-cell: Non-Hodgkins: Mantle Cell,Mantle Cell Lymphoma (C4337),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,78,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000358,NCIH69,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,55,,,,,,,,,,Male,,,,
ACH-000359,MG63,,,,,Bone Cancer,Osteosarcoma,Osteosarcoma (C9145),Primary,Cell Line Onboarding,Vendor,Bone,14,Pediatric,,,,,,,,,Male,,,,
ACH-000360,NCIH508,,,,,Colon/Colorectal Cancer,Caecum Adenocarcinoma,Cecum Adenocarcinoma (C5543),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,55,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000361,SKHEP1,,,,,Liver Cancer,Hepatocellular Adenocarcinoma,Hepatocellular Carcinoma (C3099),Metastasis,Cell Line Onboarding,Vendor,ascites,52,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000362,MOLM13,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,20,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000363,SKMM2,,,,,Leukemia,Plasma Cell,Plasma Cell Leukemia (C3180),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,54,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000364,U2OS,,,,,Bone Cancer,Osteosarcoma,Osteosarcoma (C9145),Primary,Cell Line Onboarding,Vendor,Bone,15,Pediatric,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000365,SUDHL4,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,38,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000366,SKNDZ,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,2,Pediatric,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + NEAA
ACH-000367,NCIH226,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,,
ACH-000368,SNU1105,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,61,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000369,MOLM16,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,77,,,,,,,,,,Female,,,,RPMI + 20% heat inactivated FBS
ACH-000370,SNU626,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,65,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000371,RL,,,,,Lymphoma,B-cell: Non-Hodgkins,B-Cell Non-Hodgkin Lymphoma (C3457),Unknown,Cell Line Onboarding,Vendor,ascites,52,,,,,,,,,,Male,,,,RPMI + 20% FBS
ACH-000372,P12ICHIKAWA,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,7,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000373,SKM1,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,76,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000374,HCC1143,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,52,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000376,SF295,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,67,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000377,SNU478,,,,,Bile Duct Cancer,Cholangiocarcinoma: extrahepatic: ampullary,Ampulla of Vater Adenocarcinoma (C6650),Unknown,Cell Line Onboarding,Vendor,Biliary Tract,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/l L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000378,NCIH647,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenosquamous Carcinoma,Adenosquamous Lung Carcinoma (C9133),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,56,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000379,NCIH1781,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,66,,,,,,,,,,Female,,,,
ACH-000380,KMS12BM,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Bone Marrow,64,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000381,T84,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Lung,72,,,,,,,,,,Male,,,2D Adherent,DMEM:F12(1:1) + 5% FBS + 2mM Glutamine
ACH-000382,CORL24,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,71,,,,,,,,,,Male,,,,
ACH-000383,OE33,,,,,Esophageal Cancer,Adenocarcinoma,Esophageal Adenocarcinoma (C4025),Primary,Cell Line Onboarding,Vendor,Esophagus,73,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000384,SW780,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,80,,,,,,,,,,Female,,,2D Adherent,L15 + 10% FBS
ACH-000386,KG1,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Primary,Cell Line Onboarding,Vendor,Bone Marrow,59,Pediatric,,,,,,,,,Male,,,,
ACH-000387,TF1,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,35,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS + 2ng/ml GM-CSF
ACH-000388,NUDHL1,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,73,,,,,,,,,,Male,,,,RPMI + 20% FBS
ACH-000389,H4,,,,,Brain Cancer,Neuroglioma,Glioma (C3059),Primary,Cell Line Onboarding,Vendor,Central Nervous System,37,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000390,LUDLU1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,72,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000391,MHHES1,,,,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Metastasis,Cell Line Onboarding,Vendor,ascites,12,Pediatric,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000392,CALU3,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,25,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000393,HLF,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,69,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000394,NCIH2081,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,59,,,,,,,,,,Female,,,,
ACH-000395,NCIH520,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000396,J82,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,58,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000397,TEN,,,,,Endometrial/Uterine Cancer,Clear Cell Carcinoma,Endometrial Clear Cell Adenocarcinoma (C8028),Primary,Cell Line Onboarding,Vendor,Endometrium,74,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000398,RI1,,,,,Lymphoma,B-cell: Non-Hodgkins,B-Cell Non-Hodgkin Lymphoma (C3457),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,57,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000399,NCIH2196,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,67,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 30nM Selenium + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000400,SKCO1,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,ascites,65,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000401,COLO800,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,14,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000402,BL70,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,16,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS + 1mM Sodium pyruvate + 50uM 2-Mercaptoethanol
ACH-000403,NCIH747,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Large Intestine,69,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000404,K029AX,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Academic lab,Skin,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000405,MEC1,,,,,Leukemia,Chronic Lymphoblastic Leukemia (CLL): B-cell,Chronic Lymphocytic Leukemia (C3163),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,61,,,,,,,,,,Male,,,2D Suspension,IMDM + 10% FBS
ACH-000406,U937,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,37,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000407,SNU685,,,,,Endometrial/Uterine Cancer,Malignant Mixed Mullerian Tumor (MMMT),Malignant Mixed Mesodermal (Mullerian) Tumor (C8975),Primary,Cell Line Onboarding,Vendor,Endometrium,70,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000408,TE5,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Unknown,Cell Line Onboarding,Vendor,Esophagus,73,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000409,OVSAHO,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,56,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000410,SAOS2,,,,,Bone Cancer,Osteosarcoma,Osteosarcoma (C9145),Primary,Cell Line Onboarding,Vendor,Bone,11,Pediatric,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 15% FBS
ACH-000411,769P,,,,,Kidney Cancer,Renal Adenocarcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Primary,Cell Line Onboarding,Vendor,Kidney,63,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000412,SNU1197,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Colon,70,,,,,,,,,,Male,,,2D Adherent,
ACH-000413,HS739T,,,,,Fibroblast,Breast carcinoma,Fibroblast,Unknown,Cell Line Onboarding,Unknown,Fibroblast,52,,,,,,,,,,Female,,,,
ACH-000414,NCIH1944,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,62,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000415,BICR6,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000416,NCIH838,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,59,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000417,PANC0813,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,85,,,,,,,,,,Male,,,2D Adherent,RPMI + 15% FBS + 2mM Glutamine + 1mM Sodium pyruvate + 60ug/ml Insulin + 10mM HEPES + 1.5g/l Sodium bicarbonate + 4.5g/l Glucose
ACH-000417,PANC0813,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,85,,,,,,,,,,Male,,,2D Adherent,RPMI + 15% FBS + 2mM Glutamine + 1mM Sodium pyruvate + 60ug/ml Insulin + 10mM HEPES + 1.5g/l Sodium bicarbonate + 4.5g/l Glucose
ACH-000418,SW1353,,,,,Bone Cancer,Chondrosarcoma,Chondrosarcoma (C2946),Primary,Cell Line Onboarding,Vendor,Bone,72,,,,,,,,,,Female,,,,
ACH-000419,KMS28BM,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,77,,,,,,,,,,Female,,,,
ACH-000420,SNU449,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,52,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000421,SW837,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Large Intestine,53,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000422,SNU475,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,43,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000423,SKMEL3,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,42,,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 15% FBS
ACH-000424,TC71,,,,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Primary,Cell Line Onboarding,Vendor,Bone,22,Pediatric,,,,,,,,,Male,,,2D Adherent,IMDM + 10% FBS
ACH-000424,TC71,,,,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Primary,Cell Line Onboarding,Vendor,Bone,22,Pediatric,,,,,,,,,Male,,,2D Adherent,IMDM + 10% FBS
ACH-000425,UACC62,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000426,KMS20,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Bone Marrow,65,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000427,NCIN87,,,,,Gastric Cancer,Adenocarcinoma: tubular,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Liver,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000428,UO31,,,,,Kidney Cancer,Unknown,Kidney Carcinoma (C9384),Unknown,Cell Line Onboarding,Academic lab,Kidney,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 5% FBS
ACH-000429,A704,,,,,Kidney Cancer,Renal Cell Adenocarcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,78,,,,,,,,,,Male,,,,MEM + 10% FBS
ACH-000430,TYKNU,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Primary,Cell Line Onboarding,Vendor,Ovary,Unknown,,,,,,,,,,Female,,,,MEM + 10% FBS
ACH-000432,BV173,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,45,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS + 2mM Glutamax
ACH-000433,CAKI1,,,,,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Metastasis,Cell Line Onboarding,Vendor,Skin,49,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000434,NCIH1915,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Central Nervous System,61,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000435,EFE184,,,,,Endometrial/Uterine Cancer,Endometrial Carcinoma,Endometrial Carcinoma (C7558),Metastasis,Cell Line Onboarding,Vendor,ascites,69,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000437,SW1088,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Primary,Cell Line Onboarding,Vendor,Central Nervous System,72,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000438,LU65,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Primary,Cell Line Onboarding,Vendor,Lung,64,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000440,CA46,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000441,SH4,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,60,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000442,RERFLCSQ1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,74,,,,,,,,,,Female,,,,
ACH-000443,OVKATE,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Primary,Cell Line Onboarding,Vendor,Ovary,40,,,,,,,,,,Female,,,,
ACH-000444,LU99,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Pleura,63,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000445,KNS60,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,55,,,,,,,,,,Male,,,2D Adherent,DMEM + 5% FBS
ACH-000446,KPNSI9S,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Autonomic Ganglia,Unknown,Pediatric,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000447,NCIH2228,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Female,,,,
ACH-000448,NCIH1666,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Female,,,2D Mixed adherent and suspension,ACL4
ACH-000449,MESSA,,,,,Sarcoma,Uterine Sarcoma,Sarcoma (C9118),Primary,Cell Line Onboarding,Vendor,Endometrium,56,,,,,,,,,,Female,,,,
ACH-000450,MELHO,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000451,NCIH2085,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,45,,,,,,,,,,Male,,,,
ACH-000452,TE8,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Unknown,Cell Line Onboarding,Vendor,Esophagus,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000453,MOLP2,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,55,,,,,,,,,,Male,,,,
ACH-000454,HCC95,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,65,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000456,BCPAP,,,,,Thyroid Cancer,Carcinoma: papillary,Thyroid Gland Papillary Carcinoma (C4035),Primary,Cell Line Onboarding,Vendor,thyroid,76,,,,,,,,,,Female,,,2D Adherent,
ACH-000457,CAL54,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,75,,,,,,,,,,Male,,,,DMEM + 15% FBS + 4mM L-glutamine + 0.4ug/ml Hydrocortisone + 10ng/ml EGF
ACH-000458,CJM,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Unknown,,,2D Adherent,F12 + 10% FBS
ACH-000459,TUHR10TKB,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,69,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000460,SNU8,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,55,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000461,SNU1196,,,,,Bile Duct Cancer,Cholangiocarcinoma: extrahepatic,Cholangiocarcinoma (C4436),Unknown,Cell Line Onboarding,Vendor,Biliary Tract,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000462,NALM1,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,3,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000463,NCIH460,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000464,CAS1,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,63,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000465,SKMEL1,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,29,,,,,,,,,,Male,,,2D Suspension,MEM + 10% FBS
ACH-000466,SNU216,,,,,Gastric Cancer,Adenocarcinoma: tubular,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,46,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000467,HCC56,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Unknown,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Unknown,,,2D Adherent,MEM + 10% FBS
ACH-000468,PK45H,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000469,YH13,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,40,,,,,,,,,,Male,,,2D Adherent,MEM + 20% FBS
ACH-000470,SW1463,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Large Intestine,66,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000471,LI7,,,,,Liver Cancer,Unknown,Hepatocellular Carcinoma (C3099),Unknown,Cell Line Onboarding,Vendor,Liver,45,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000472,HSC2,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Metastasis,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,69,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000473,RT112,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000475,HUH1,,,,,Liver Cancer,Hepatocellular Carcinoma: HBs-antigen carrier,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,53,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000476,JHH4,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,51,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000477,MALME3M,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lung,43,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000478,SNU387,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,41,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000479,KNS81,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,65,,,,,,,,,,Male,,,2D Adherent,DMEM + 5% FBS
ACH-000480,HUH7,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,57,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000481,NCIH2170,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000482,RERFLCKJ,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,78,,,,,,,,,,Male,,,,
ACH-000483,SNU182,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,24,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000484,VMRCRCW,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000485,GSU,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,ascites,37,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000486,KU1919,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Unknown,Cell Line Onboarding,Vendor,Urinary Tract,76,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS
ACH-000487,F36P,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M6 (Erythroleukemia),Acute Erythroid Leukemia (C8923),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,68,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS + 10ng/ml GM-CSF
ACH-000488,TE11,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,58,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000489,SW1116,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Primary,Cell Line Onboarding,Vendor,Colon,73,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000491,NCIH716,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,ascites,33,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000492,MUTZ5,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,26,Pediatric,,,,,,,,,Male,,,,RPMI + 20% FBS
ACH-000493,SNU423,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,40,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000495,TUHR4TKB,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,60,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000496,NCIH1792,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000498,KO52,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M2 (Myeloblastic),Acute Myeloid Leukemia with Maturation (C3250),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,46,Pediatric,,,,,,,,,Male,,,2D Suspension,AlphaMEM + 10% heat inactivated FBS
ACH-000500,SNU46,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: laryngeal,Laryngeal Squamous Cell Carcinoma (C4044),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,66,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/l L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000501,LS123,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,65,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000502,TCCPAN2,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,ascites,68,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000503,BICR16,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000504,SNB75,,,,,Brain Cancer,Glioma,Glioma (C3059),Primary,Cell Line Onboarding,Academic lab,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 5% FBS
ACH-000505,RKN,,,,,Sarcoma,Leiomyosarcoma,Leiomyosarcoma (C3158),Primary,Cell Line Onboarding,Vendor,Ovary,45,,,,,,,,,,Female,,,2D Adherent,F12 + 10% FBS
ACH-000506,NCIH146,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,59,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000507,KE39,,,,,Gastric Cancer,Carcinoma,Gastric Carcinoma (C4911),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,77,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000508,CORL88,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,55,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS + 2mM Glutamine
ACH-000510,NCIH1299,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,43,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000511,CALU1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Pleura,47,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000513,SNU1272,,,,,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Unknown,Cell Line Onboarding,Vendor,Kidney,63,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000514,NCIH1092,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,67,,,,,,,,,,Male,,,2D Suspension,RPMI + 5% FBS + 2mM L-glutamine + 5ml Insulin-Transferrin-Selenium + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000515,HCC33,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,52,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000516,CAL78,,,,,Bone Cancer,Chondrosarcoma,Chondrosarcoma (C2946),Unknown,Cell Line Onboarding,Vendor,Soft Tissue,76,,,,,,,,,,Male,,,2D Adherent,RPMI + 20% FBS
ACH-000518,CAL33,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,69,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000519,PEER,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,4,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000520,59M,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM Glutamine + Sodium pyruvate + Insulin-Transferrin-Selenium
ACH-000521,NCIH2030,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000522,UMUC3,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000523,NCIH1184,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,42,,,,,,,,,,Male,,,,
ACH-000524,KURAMOCHI,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000525,NCIH2171,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Male,,,2D Suspension,RPMI + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 10ug/ml Transferrin + 30nM Selenium + 10mM HEPES + 10nM Hydrocortisone
ACH-000526,HS821T,,,,,Fibroblast,Giant Cell Sarcoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,31,,,,,,,,,,Female,,,,DMEM + 10% FBS
ACH-000527,OVISE,,,,,Ovarian Cancer,Adenocarcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Metastasis,Cell Line Onboarding,Vendor,Bone,40,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000528,ABC1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,47,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000529,T173,,,,,Fibroblast,Osteosarcoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,Unknown,Pediatric,,,,,,,,,Unknown,,,2D Adherent,DMEM + 10% FBS
ACH-000530,DMS114,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,68,,,,,,,,,,Male,,,,Waymouth's MB 752/1 + 10% FBS + 1mM Glutamine + 1.5g/l Sodium bicarbonate
ACH-000531,RS5,,,,,Fibroblast,Mesothelioma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,78,,,,,,,,,,Male,,,,
ACH-000532,SNU61,,,,,Colon/Colorectal Cancer,Colorectal Carcinoma,Colorectal Carcinoma (C2955),Metastasis,Cell Line Onboarding,Vendor,Liver,48,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000534,WSUDLCL2,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,41,,,,,,,,,,Male,,,,
ACH-000535,BXPC3,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,61,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000535,BXPC3,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,61,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000536,BT20,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,74,,,,,,,,,,Female,,,,MEM + 10% FBS
ACH-000537,SNU761,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Unknown,Cell Line Onboarding,Vendor,Liver,49,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000538,HUTU80,,,,,Gastric Cancer,Duodenal Adenocarcinoma,Duodenal Adenocarcinoma (C7889),Primary,Cell Line Onboarding,Vendor,Small Intestine,53,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000539,HS618T,,,,,Fibroblast,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,60,,,,,,,,,,Female,,,,
ACH-000540,HS606T,,,,,Fibroblast,Breast carcinoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,44,,,,,,,,,,Female,,,,DMEM + 10% FBS
ACH-000541,KMS34,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Pleural Effusion,60,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000542,HEYA8,,,,,Ovarian Cancer,Adenocarcinoma: low grade serous,Low Grade Ovarian Serous Adenocarcinoma (C105556),Metastasis,Cell Line Onboarding,Academic lab,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000543,SNU489,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,54,,,,,,,,,,Male,,,,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000544,OE21,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,74,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000545,VMCUB1,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000546,HSC4,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Metastasis,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,64,,,,,,,,,,Male,,,,
ACH-000547,HT1197,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Primary,Cell Line Onboarding,Vendor,Urinary Tract,44,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000548,BHY,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,52,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000549,SNU1076,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: laryngeal,Laryngeal Squamous Cell Carcinoma (C4044),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,60,,,,,,,,,,Male,,,,RPMI + 10% heat inactivated FBS + 300mg/l L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000550,IGR39,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,26,,,,,,,,,,Male,,,2D Adherent,DMEM + 15% FBS
ACH-000551,K562,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,53,,,,,,,,,,Female,,,2D Suspension,IMDM + 10% FBS
ACH-000553,SQ1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000554,UACC893,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,57,,,,,,,,,,Female,,,,
ACH-000555,A498,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,52,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000557,AML193,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Monocytic),Acute Monocytic Leukemia (C4861),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,13,Pediatric,,,,,,,,,Female,,,2D Suspension,IMDM + 5% FBS + 10ug/ml Insulin + 5ug/ml Transferrin + 2ng/ml GM-CSF
ACH-000558,A172,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,53,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000559,NCIH1836,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,52,,,,,,,,,,Male,,,,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 30nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000560,ECC10,,,,,Gastric Cancer,Small Cell Carcinoma,Gastric Small Cell Neuroendocrine Carcinoma (C6764),Unknown,Cell Line Onboarding,Vendor,Liver,Unknown,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000561,TDOTT,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Metastasis,Cell Line Onboarding,Vendor,Bone,Unknown,,,,,,,,,,Male,,,,F12 + 10% FBS
ACH-000562,HCC78,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,65,,,,,,,,,,Male,,,,
ACH-000563,EBC1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Skin,69,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000564,KHM1B,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Pleural Effusion,53,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000565,RCM1,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Primary,Cell Line Onboarding,Vendor,Large Intestine,73,,,,,,,,,,Female,,,2D Adherent,RPMI:F12 (1:1) + 20% FBS
ACH-000566,SW1710,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,84,,,,,,,,,,Female,,,2D Adherent,DMEM + 15% FBS
ACH-000567,ST486,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000568,UACC812,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,43,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 20% FBS
ACH-000569,ISTMES1,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Primary,Cell Line Onboarding,Vendor,Pleural Effusion,70,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM Glutamax
ACH-000570,YKG1,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000571,T98G,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,61,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000572,G361,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,31,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000573,MDAMB436,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,43,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS + 16ug/ml Glutathione
ACH-000574,FUOV1,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Primary,Cell Line Onboarding,Vendor,Ovary,65,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000576,KMS27,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,52,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000577,JHH2,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Metastasis,Cell Line Onboarding,Vendor,ascites,57,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000578,HCC1171,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,58,,,,,,,,,,Male,,,,
ACH-000579,UACC257,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000580,C32,,,,,Skin Cancer,Melanoma: amelanotic,Amelanotic Melanoma (C3802),Primary,Cell Line Onboarding,Vendor,Skin,53,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS + 0.1mM NEAA
ACH-000581,SNU16,,,,,Gastric Cancer,Carcinoma,Gastric Carcinoma (C4911),Metastasis,Cell Line Onboarding,Vendor,ascites,33,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000582,COLO741,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,69,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000582,COLO741,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,69,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000583,MC116,,,,,Lymphoma,B-cell: Non-Hodgkins,B-Cell Non-Hodgkin Lymphoma (C3457),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,,RPMI + 20% FBS
ACH-000584,JHOS4,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Primary,Cell Line Onboarding,Vendor,Ovary,44,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS
ACH-000585,EPLC272H,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,57,,,,,,,,,,Male,,,2D Adherent,RPMI + 20% FBS
ACH-000586,NCIH1876,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,59,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + 5ml Insulin-Transferrin-Selenium
ACH-000588,KMS26,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000589,NCIH1437,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,60,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000590,NCIH2073,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,47,,,,,,,,,,Female,,,,
ACH-000592,TM31,,,,,Brain Cancer,Glioma,Glioma (C3059),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,42,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000593,BC3C,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,82,,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000594,DMS153,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Liver,44,,,,,,,,,,Male,,,,
ACH-000595,LN229,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,60,,,,,,,,,,Female,,,2D Adherent,DMEM + 5% FBS
ACH-000596,LCLC97TM1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Primary,Cell Line Onboarding,Vendor,Lung,44,,,,,,,,,,Male,,,2D Adherent,RPMI + 20% FBS
ACH-000598,KMS21BM,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,62,,,,,,,,,,Male,,,,
ACH-000599,PATU8902,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,44,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000599,PATU8902,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,44,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000601,MIAPACA2,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,65,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000602,M07E,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M7 (Megakaryoblastic),Acute Megakaryoblastic Leukemia (C3170),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,0.5,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS + 10ng/ml GM-CSF
ACH-000603,BEN,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): unspecified,Non-Small Cell Lung Carcinoma (C2926),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,71,,,,,,,,,,Male,,,,
ACH-000604,KYO1,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,22,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000605,TE6,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Unknown,Cell Line Onboarding,Vendor,Esophagus,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000606,PECAPJ34CLONEC12,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: basaloid,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,60,,,,,,,,,,Male,,,2D Adherent,IMDM + 10% FBS + 2mM Glutamine
ACH-000607,KYM1,,,,,Rhabdoid,Malignant Rhabdoid Tumor,Atypical Teratoid/Rhabdoid Tumor (C6906),Primary,Cell Line Onboarding,Vendor,Soft Tissue,1,Pediatric,,,,,,,,,Male,,,,DMEM:F12 (1:1) + 10% FBS
ACH-000608,COV644,,,,,Ovarian Cancer,Carcinoma: epithelial-mucinous,Ovarian Mucinous Adenocarcinoma (C5243),Primary,Cell Line Onboarding,Vendor,Ovary,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM L-glutamine
ACH-000609,SF126,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Primary,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000610,NCIH2227,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,54,,,,,,,,,,Male,,,,
ACH-000611,SUDHL6,,,,,Lymphoma,Diffuse Mixed Small and Large B-cell Lymphoma,Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,ascites,43,,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000612,HUT102,,,,,Lymphoma,T-cell,T-Cell Non-Hodgkin Lymphoma (C3466),Unknown,Cell Line Onboarding,Vendor,Lymph Node,26,,,,,,,,,,Male,,,,
ACH-000613,HOS,,,,,Bone Cancer,Osteosarcoma,Osteosarcoma (C9145),Primary,Cell Line Onboarding,Vendor,Bone,13,Pediatric,,,,,,,,,Female,,,,
ACH-000614,RVH421,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Central Nervous System,28,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000615,SKMEL28,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Vendor,Skin,51,,,,,,,,,,Male,,,,
ACH-000616,HS746T,,,,,Gastric Cancer,Carcinoma,Gastric Carcinoma (C4911),Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,74,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000617,OVCAR4,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,ascites,42,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000618,SNU1041,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: hypopharyngeal,Hypopharyngeal Squamous Cell Carcinoma (C4043),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/l L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000619,PECAPJ15,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,45,,,,,,,,,,Male,,,,IMDM + 10% FBS + 2mM Glutamine
ACH-000620,JHH1,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,50,,,,,,,,,,Male,,,2D Adherent,William's E Medium + 10% FBS
ACH-000621,MDAMB157,,,,,Breast Cancer,Breast Ductal Carcinoma: medullary,Medullary Breast Carcinoma (C9119),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,44,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000622,KNS42,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,16,Pediatric,,,,,,,,,Male,,,2D Adherent,MEM + 5% FBS
ACH-000623,SNU201,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,58,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000624,HCC1806,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,60,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000625,HEP3B217,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,8,,,,,,,,,,Male,,,2D Mixed adherent and suspension,MEM + 10% FBS
ACH-000626,U266B1,,,,,Myeloma,Multiple Myeloma: plasmacytoma,Plasmacytoma (C9349),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,53,,,,,,,,,,Male,,,,
ACH-000627,LCLC103H,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,61,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000628,NCIH596,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenosquamous Carcinoma,Adenosquamous Lung Carcinoma (C9133),Primary,Cell Line Onboarding,Vendor,Lung,73,,,,,,,,,,Male,,,,
ACH-000630,YD8,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: tongue,Tongue Squamous Cell Carcinoma (C4648),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,46,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000631,KS1,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS + 2mM Glutamax
ACH-000632,HS944T,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,51,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000633,FU97,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Cell Line Onboarding,Vendor,stomach,66,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 0.01mg/ml Insulin
ACH-000635,SNU119,,,,,Ovarian Cancer,Cystadenocarcinoma: high grade serous,Ovarian Cystadenocarcinoma (C5228),Metastasis,Cell Line Onboarding,Vendor,ascites,50,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000636,RPMI8402,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,16,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000637,KYSE520,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,58,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000638,NCIH441,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pericardial Effusion,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000639,NCIH211,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,50,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000640,SKMEL31,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Female,,,,
ACH-000641,CMK,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M7 (Megakaryoblastic),Acute Megakaryoblastic Leukemia (C3170),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,0.8333,Pediatric,,,,,,,,,Male,,,,RPMI + 20% FBS
ACH-000643,HDQP1,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,50,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000644,COLO829,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,45,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000645,JL1,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Primary,Cell Line Onboarding,Vendor,Pleura,54,,,,,,,,,,Male,,,2D Adherent,DMEM + 20% FBS
ACH-000646,OVMANA,,,,,Ovarian Cancer,Adenocarcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Primary,Cell Line Onboarding,Vendor,Ovary,51,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000647,TE1,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000648,NCIH28,,,,,Lung Cancer,Mesothelioma,Mesothelioma (C3234),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,48,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000649,786O,,,,,Kidney Cancer,Renal Adenocarcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Primary,Cell Line Onboarding,Vendor,Kidney,58,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000650,IGR37,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,26,,,,,,,,,,Male,,,2D Adherent,DMEM + 15% FBS
ACH-000651,SW620,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,51,,,,,,,,,,Male,,,2D Mixed adherent and suspension,L15 + 10% FBS
ACH-000652,SUIT2,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: tubular,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,73,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000653,JJN3,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Bone Marrow,57,,,,,,,,,,Female,,,2D Suspension,DMEM:IMDM (1:1) + 20% FBS
ACH-000654,RAJI,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,Bone,12,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000655,SF268,,,,,Brain Cancer,Glioma,Glioma (C3059),Primary,Cell Line Onboarding,Academic lab,Central Nervous System,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 5% FBS
ACH-000656,SUDHL8,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,59,,,,,,,,,,Male,,,,
ACH-000657,A2780,,,,,Ovarian Cancer,Adenocarcinoma: endometrioid,Ovarian Endometrioid Adenocarcinoma (C7979),Primary,Cell Line Onboarding,Vendor,Ovary,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000659,SCLC21H,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,46,,,,,,,,,,Male,,,,
ACH-000660,SUDHL5,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Cell Line Onboarding,Vendor,Lymph Node,17,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000661,WM1799,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000662,CORL23,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,62,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 2mM Glutamine
ACH-000663,OVTOKO,,,,,Ovarian Cancer,Adenocarcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Metastasis,Cell Line Onboarding,Vendor,Spleen,78,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000665,SKMES1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,65,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000666,NCIH1355,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,53,,,,,,,,,,Male,,,2D Suspension,ACL4
ACH-000667,HCC44,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,54,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000668,HCC70,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,49,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000669,SW900,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,53,,,,,,,,,,Male,,,,
ACH-000670,SBC5,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,,
ACH-000671,HUH6,,,,,Liver Cancer,Hepatoblastoma,Hepatocellular Carcinoma (C3099),Unknown,Cell Line Onboarding,Vendor,Liver,Unknown,Pediatric,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000672,IALM,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Skin,68,,,,,,,,,,Male,,,2D Adherent,F12 + 10% FBS
ACH-000674,NUGC4,,,,,Gastric Cancer,Adenocarcinoma: signet ring cell,Signet Ring Cell Gastric Adenocarcinoma (C5250),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,35,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000675,NCIH1734,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,56,,,,,,,,,,Female,,,,
ACH-000677,SW1573,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Primary,Cell Line Onboarding,Vendor,Lung,44,,,,,,,,,,Female,,,2D Adherent,L15 + 10% FBS
ACH-000678,MKN7,,,,,Gastric Cancer,Adenocarcinoma: tubular,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,39,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000679,OE19,,,,,Esophageal Cancer,Squamous Cell Carcinoma: laryngeal,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,72,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 2mM Glutamine
ACH-000680,SW948,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Primary,Cell Line Onboarding,Vendor,Colon,81,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000681,A549,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,58,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000682,SNU1066,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,62,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000683,SNU503,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,52,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000684,KMRC1,,,,,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000685,L33,,,,,Pancreatic Cancer,Ductal Adenosquamous Carcinoma,Pancreatic Carcinoma (C3850),Metastasis,Cell Line Onboarding,Academic lab,Lymph Node,Unknown,,,,,,,,,,Female,,,2D Mixed adherent and suspension,DMEM + 10% FBS + 2mM Glutamine + 1mM Sodium pyruvate + 1mM NEAA
ACH-000686,SNU878,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,54,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000687,CI1,,,,,Lymphoma,B-cell: Non-Hodgkins,B-Cell Non-Hodgkin Lymphoma (C3457),Unknown,Cell Line Onboarding,Vendor,ascites,38,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000688,OV7,,,,,Ovarian Cancer,Carcinoma: mixed,Ovarian Carcinoma (C4908),Primary,Cell Line Onboarding,Vendor,Ovary,78,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 10ug/ml Insulin + 0.5ug/ml Hydrocortisone
ACH-000689,RH18,,,,,Sarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma (C3359),Unknown,Cell Line Onboarding,Vendor,Soft Tissue,2,,,,,,,,,,Female,,,2D Adherent,RPMI + 20% heat inactivated FBS
ACH-000691,HCC2157,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,48,,,,,,,,,,Female,,,,RPMI + 5% FBS
ACH-000692,SNU899,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: laryngeal,Laryngeal Squamous Cell Carcinoma (C4044),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,56,,,,,,,,,,Male,,,,
ACH-000693,KYSE180,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,53,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000694,TE9,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000695,CORL47,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,67,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS + 2mM Glutamax
ACH-000696,OVCAR8,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Primary,Cell Line Onboarding,Vendor,Ovary,64,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000697,A3KAW,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Primary,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000698,DMS53,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,54,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000699,HCC1395,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,43,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000701,RMUGS,,,,,Ovarian Cancer,Cystadenocarcinoma: mucinous,Ovarian Cystadenocarcinoma (C5228),Primary,Cell Line Onboarding,Vendor,Ovary,62,,,,,,,,,,Female,,,2D Adherent,F12 + 10% FBS
ACH-000702,L1236,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,34,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000703,DMS79,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,65,,,,,,,,,,Male,,,,
ACH-000704,OAW42,,,,,Ovarian Cancer,Carcinoma,Ovarian Carcinoma (C4908),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,,DMEM + 10% FBS + 2mM L-glutamine + 0.9mg/L Insulin (Bovine)
ACH-000705,LC1F,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,69,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000707,P3HR1,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,ascites,7,,,,,,,,,,Male,,,,RPMI + 20% FBS
ACH-000708,SNU283,,,,,Colon/Colorectal Cancer,Colorectal Carcinoma,Colorectal Carcinoma (C2955),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,62,,,,,,,,,,Female,,,,RPMI + 10% heat inactivated FBS + HEPES + Pen-Strep
ACH-000709,KMRC2,,,,,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Primary,Cell Line Onboarding,Vendor,Kidney,Unknown,,,,,,,,,,Male,,,2D Adherent,F12 + 10% FBS
ACH-000710,NCIH854,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000711,JIMT1,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,62,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000712,HCC1833,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,69,,,,,,,,,,Female,,,,
ACH-000713,CAOV3,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Primary,Cell Line Onboarding,Vendor,Ovary,54,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000714,KMS11,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Pleural Effusion,67,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000715,SNU1214,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: laryngeal,Laryngeal Squamous Cell Carcinoma (C4044),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,55,,,,,,,,,,Male,,,,
ACH-000716,TT2609C02,,,,,Thyroid Cancer,Carcinoma: follicular,Thyroid Gland Follicular Carcinoma (C8054),Unknown,Cell Line Onboarding,Vendor,thyroid,57,,,,,,,,,,Male,,,2D Adherent,RPMI + 20% FBS
ACH-000717,COLO680N,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Unknown,Cell Line Onboarding,Vendor,Esophagus,57,,,,,,,,,,Female,,,,
ACH-000718,NCIH2291,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000719,RMGI,,,,,Ovarian Cancer,Adenocarcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Metastasis,Cell Line Onboarding,Vendor,ascites,34,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000720,TCCSUP,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,67,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS + 1mM Sodium pyruvate + 1mM NEAA
ACH-000721,HMC18,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,35,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000722,SNUC1,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,71,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000723,YD10B,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: tongue,Tongue Squamous Cell Carcinoma (C4648),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,67,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (3:1) + 10% heat inactivated FBS + 5ug/ml Insulin + 5ug/ml Transferrin + 0.4ug/ml Hydrocortisone + 0.1nM Cholera toxin + 0.02nM Triiodothyronine
ACH-000724,HT1376,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Primary,Cell Line Onboarding,Vendor,Urinary Tract,58,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000725,HCC202,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,82,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000726,TE14,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Unknown,Cell Line Onboarding,Vendor,Esophagus,Unknown,,,,,,,,,,Male,,,,
ACH-000727,NCIH2066,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,70,,,,,,,,,,Female,,,,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 30nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000728,KASUMI2,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,15,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS
ACH-000729,NCIH1963,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,56,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000730,SKMEL5,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,24,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000731,HCC2279,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,52,,,,,,,,,,Female,,,,
ACH-000732,PECAPJ41CLONED2,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,67,,,,,,,,,,Female,,,2D Adherent,IMDM + 10% FBS + Glutamax
ACH-000733,NCIH1838,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Female,,,,
ACH-000734,JHH5,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,50,,,,,,,,,,Male,,,2D Adherent,William's E Medium + 10% FBS
ACH-000735,PECAPJ49,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,57,,,,,,,,,,Male,,,2D Adherent,IMDM + 10% FBS + 2mM Glutamine
ACH-000736,SNU601,,,,,Gastric Cancer,Adenocarcinoma: signet ring cell,Signet Ring Cell Gastric Adenocarcinoma (C5250),Metastasis,Cell Line Onboarding,Vendor,ascites,34,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000737,NCIH1385,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Female,,,,
ACH-000738,GB1,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,35,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000739,HEPG2,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,15,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000740,A253,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: salivary gland,Salivary Gland Squamous Cell Carcinoma (C7991),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,54,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000741,UBLC1,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM:RPMI (1:3) + 10% FBS + 2mM Glutamine
ACH-000742,DM3,,,,,Fibroblast,Mesothelioma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Fibroblast,62,,,,,,,,,,Male,,,,
ACH-000743,CORL95,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,64,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000744,NCIH1623,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,58,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000745,MOLP8,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,52,,,,,,,,,,Male,,,,
ACH-000746,GSS,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Liver,75,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000747,NCIH1703,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,54,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000748,SJSA1,,,,,Bone Cancer,Osteosarcoma: Multipotential Sarcoma,Osteosarcoma (C9145),Primary,Cell Line Onboarding,Vendor,Bone,19,Pediatric,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000749,DMS273,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Female,,,,Waymouth's MB 752/1 + 10% heat inactivated FBS + 2mM Glutamine
ACH-000750,LOXIMVI,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,58,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000751,OCIM1,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M6 (Erythroleukemia),Acute Erythroid Leukemia (C8923),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,62,Pediatric,,,,,,,,,Unknown,,,2D Suspension,IMDM + 10% FBS
ACH-000752,NCIH196,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,68,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000753,JMSU1,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Metastasis,Cell Line Onboarding,Vendor,ascites,75,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 2mM Glutamax
ACH-000754,L428,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,37,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000755,HCC2218,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,38,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000756,GI1,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,61,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000758,MKN74,,,,,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Liver,37,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000759,MDAMB175VII,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,56,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000761,NUGC2,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,56,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000762,YD38,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Unknown,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,67,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000763,MM1S,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Academic lab,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000764,SH10TC,,,,,Gastric Cancer,Adenocarcinoma: mucinous,Mucinous Gastric Adenocarcinoma (C5248),Primary,Cell Line Onboarding,Vendor,stomach,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000765,WM983B,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Academic lab,Lymph Node,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000766,NCIH1648,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,39,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000767,NCIH526,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,55,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000768,MDAMB231,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,51,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000769,LK2,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000770,P31FUJ,,,,,Leukemia,Acute Myelogenous Leukemia (AML): M5 (Monocytic),Acute Monocytic Leukemia (C4861),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000771,BICR56,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,Unknown,,,,,,,,,,Female,,,,DMEM + 10% FBS + 2mM Glutamine + 0.4ug/ml Hydrocortisone
ACH-000772,TE441T,,,,,Sarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma (C3359),Unknown,Cell Line Onboarding,Vendor,Soft Tissue,14,Pediatric,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000774,RERFLCAD2,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000775,NCIH727,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Primary,Cell Line Onboarding,Vendor,Lung,65,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000776,ONS76,,,,,Brain Cancer,Medulloblastoma,Medulloblastoma (C3222),Primary,Cell Line Onboarding,Vendor,Central Nervous System,2,Pediatric,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000777,KYSE30,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,64,,,,,,,,,,Male,,,2D Adherent,RPMI:F12 (1:1) + 20% FBS
ACH-000778,HSC3,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Metastasis,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,64,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000779,PC9,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Unknown,Cell Line Onboarding,Academic lab,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-000780,NCIH1105,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,73,,,,,,,,,,Male,,,2D Suspension,RPMI + 5% FBS + 5ml Insulin-Transferrin-Selenium
ACH-000781,NCIH2023,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,26,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 10nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000782,SEM,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,5,Pediatric,,,,,,,,,Female,,,2D Suspension,IMDM + 10% FBS
ACH-000783,CAMA1,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,51,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000784,KYSE70,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,77,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000785,NCIH2126,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,65,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 10nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000786,DAUDI,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,16,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000787,LXF289,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,63,,,,,,,,,,Male,,,2D Adherent,F12 + 10% FBS
ACH-000788,A2058,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,43,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000789,NCIH810,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Primary,Cell Line Onboarding,Vendor,Lung,51,,,,,,,,,,Male,,,,
ACH-000790,SHP77,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,54,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000791,RERFLCAD1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,70,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000792,BFTC909,,,,,Kidney Cancer,Renal Carcinoma: transitional cell,Renal Cell Carcinoma (C9385),Primary,Cell Line Onboarding,Vendor,Kidney,64,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000793,KATOIII,,,,,Gastric Cancer,Adenocarcinoma: signet ring cell,Signet Ring Cell Gastric Adenocarcinoma (C5250),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,55,,,,,,,,,,Male,,,2D Mixed adherent and suspension,IMDM + 20% FBS
ACH-000794,BICR22,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS + 2mM Glutamine + 0.4ug/ml Hydrocortisone
ACH-000795,MOLT13,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,2,Pediatric,,,,,,,,,Female,,,,
ACH-000796,MCAS,,,,,Ovarian Cancer,Cystadenocarcinoma: mucinous,Ovarian Cystadenocarcinoma (C5228),Primary,Cell Line Onboarding,Vendor,Ovary,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 15% FBS
ACH-000797,HLFA,,,,,Fibroblast,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Fibroblast,Primary,Cell Line Onboarding,Vendor,Fibroblast,54,,,,,,,,,,Female,,,,
ACH-000798,CL40,,,,,Colon/Colorectal Cancer,Colorectal Carcinoma,Colorectal Carcinoma (C2955),Primary,Cell Line Onboarding,Vendor,Colon,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 20% heat inactivated FBS
ACH-000799,HS695T,,,,,Skin Cancer,Melanoma: amelanotic,Amelanotic Melanoma (C3802),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,26,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000800,NCIH446,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,61,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000801,HS936T,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000802,BFTC905,,,,,Bladder Cancer,Transitional Cell Carcinoma: papillary,Bladder Papillary Urothelial Carcinoma (C7383),Primary,Cell Line Onboarding,Vendor,Urinary Tract,51,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000803,COLO668,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Central Nervous System,47,,,,,,,,,,Female,,,,
ACH-000804,NB1,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,2,Pediatric,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000805,COLO679,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,47,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000806,L540,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,20,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000807,SNU738,,,,,Brain Cancer,Oligodendroglioma: anaplastic,Anaplastic Oligodendroglioma (C4326),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,40,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000808,HUH28,,,,,Bile Duct Cancer,Cholangiocarcinoma: intrahepatic,Intrahepatic Cholangiocarcinoma (C35417),Primary,Cell Line Onboarding,Vendor,Biliary Tract,Unknown,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000809,KYSE410,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,51,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000810,SKMEL30,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,67,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000811,SKOV3,,,,,Ovarian Cancer,Cystadenocarcinoma,Ovarian Cystadenocarcinoma (C5228),Metastasis,Cell Line Onboarding,Vendor,ascites,64,,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000812,COLO783,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,48,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000813,T3M10,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Lung,40,,,,,,,,,,Male,,,,
ACH-000814,HS939T,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Vendor,Skin,24,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000815,KMH2,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,37,,,,,,,,,,Male,,,,
ACH-000816,NCIH524,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,63,,,,,,,,,,Male,,,,
ACH-000817,RPMI8226,,,,,Myeloma,Multiple Myeloma: plasmacytoma,Plasmacytoma (C9349),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,61,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000818,BT483,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,23,,,,,,,,,,Female,,,,
ACH-000819,LN18,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,65,,,,,,,,,,Male,,,2D Adherent,DMEM + 5% FBS
ACH-000820,SW403,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,51,,,,,,,,,,Female,,,2D Adherent,L15 + 10% FBS
ACH-000821,EJM,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,ascites,58,,,,,,,,,,Female,,,2D Mixed adherent and suspension,IMDM + 10% FBS
ACH-000822,SKMEL24,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,67,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-000823,KYSE140,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,54,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000824,KYSE510,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,67,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000827,WM793,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,,,,2D Adherent,RPMI + 10% FBS
ACH-000828,ZR7530,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Metastasis,Cell Line Onboarding,Vendor,ascites,47,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000829,HUNS1,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Male,,,2D Suspension,RPMI + 15% FBS
ACH-000830,NCIH1436,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,39,,,,,,,,,,Male,,,2D Suspension,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 30nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000831,HEC50B,,,,,Endometrial/Uterine Cancer,Uterine/Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 15% FBS
ACH-000832,CAL27,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,56,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000834,UMUC1,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS + 2mM Glutamax + NEAA
ACH-000835,GCT,,,,,Sarcoma,Malignant Fibrous Histiocytoma,Histiocytic Sarcoma (C27349),Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,29,,,,,,,,,,Male,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000836,YD15,,,,,Head and Neck Cancer,Carcinoma: mucoepidermoid,Head and Neck Carcinoma (C35850),Unknown,Cell Line Onboarding,Vendor,Salivary Gland,39,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000837,NCIH322,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Primary,Cell Line Onboarding,Vendor,Lung,52,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 2% Glutamine
ACH-000838,AMO1,,,,,Myeloma,Multiple Myeloma: plasmacytoma,Plasmacytoma (C9349),Primary,Cell Line Onboarding,Vendor,ascites,64,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000839,SCABER,,,,,Bladder Cancer,Squamous Cell Carcinoma,Bladder Squamous Cell Carcinoma (C4031),Primary,Cell Line Onboarding,Vendor,Urinary Tract,58,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS + 2mM L-glutamine + 0.1mM Sodium pyruvate + 0.1mM NEAA
ACH-000840,HCC366,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenosquamous Carcinoma,Adenosquamous Lung Carcinoma (C9133),Primary,Cell Line Onboarding,Vendor,Lung,80,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000841,NCIH2087,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,69,,,,,,,,,,Male,,,2D Adherent,RPMI + 5% FBS
ACH-000842,SW480,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Lymph Node,50,,,,,,,,,,Male,,,,L15 + 10% FBS
ACH-000843,HARA,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,57,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000844,DMS454,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-000845,NCIH1373,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,56,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000846,FADU,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Primary,Cell Line Onboarding,Vendor,Upper Aerodigestive Tract,56,,,,,,,,,,Male,,,,MEM + 10% FBS
ACH-000847,HGC27,,,,,Gastric Cancer,Carcinoma,Gastric Carcinoma (C4911),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Unknown,,,2D Adherent,MEM + 10% FBS + 2mM L-glutamine + NEAA
ACH-000848,JHH7,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,53,,,,,,,,,,Male,,,2D Adherent,William's E medium + 10% FBS
ACH-000849,MDAMB468,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,51,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000850,HS698T,,,,,Fibroblast,Colon Adenocarcinoma,Fibroblast,Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,70,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000851,MORCPR,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000852,NCIH1435,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,35,,,,,,,,,,Female,,,,ACL4
ACH-000853,NCIH661,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,43,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000855,KYSE150,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,49,,,,,,,,,,Female,,,2D Adherent,RPMI:F12 (1:1) + 10% FBS
ACH-000856,CAL51,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,45,,,,,,,,,,Female,,,2D Adherent,DMEM + 20% FBS
ACH-000857,CAL851,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Primary,Cell Line Onboarding,Vendor,Breast,35,,,,,,,,,,Female,,,,DMEM + 10% FBS
ACH-000858,KNS62,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Central Nervous System,49,,,,,,,,,,Male,,,2D Adherent,AlphaMEM + 10% FBS
ACH-000859,HCC1954,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,61,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000860,NCIH358,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-000860,NCIH358,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-000862,KMBC2,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Primary,Cell Line Onboarding,Vendor,Urinary Tract,Unknown,,,,,,,,,,Unknown,,,2D Adherent,DMEM + 10% FBS
ACH-000863,DBTRG05MG,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,59,,,,,,,,,,Female,,,,RPMI + 10% FBS + 3.57g/l HEPES + 30mg/l L-proline + 35mg/l L-cystine + 15mg/l Hypoxanthine + 1mg/l Adenosine triphosphate + 10mg/l Adenine + 1mg/l Thymidine
ACH-000864,COLO684,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,63,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS + 2mM Glutamine
ACH-000865,KYSE450,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,59,,,,,,,,,,Male,,,2D Adherent,RPMI:F12 (1:1) + 10% FBS
ACH-000866,NCIH1048,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS + 5ml Insulin-Transferrin-Selenium
ACH-000867,CHAGOK1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Metastasis,Cell Line Onboarding,Vendor,Lung,45,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000868,HCC1195,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenosquamous Carcinoma,Adenosquamous Lung Carcinoma (C9133),Primary,Cell Line Onboarding,Vendor,Lung,47,,,,,,,,,,Male,,,,
ACH-000869,NCIH1568,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,48,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000870,NCIH1930,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,41,,,,,,,,,,Male,,,,
ACH-000871,NCIH510,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Autonomic Ganglia,56,,,,,,,,,,Male,,,,DMEM:F12 (1:1) + 10% FBS
ACH-000873,KYSE270,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Primary,Cell Line Onboarding,Vendor,Esophagus,79,,,,,,,,,,Male,,,2D Adherent,RPMI:F12 (1:1) + 10% FBS
ACH-000874,RS411,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Primary,Cell Line Onboarding,Vendor,Bone Marrow,32,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000875,NCIH2347,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,54,,,,,,,,,,Female,,,,
ACH-000876,MDAMB415,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,38,,,,,,,,,,Female,,,2D Adherent,L15 + 15% FBS + 2mM Glutamine + 10ug/ml Insulin + 10ug/ml Glutathione
ACH-000877,EB1,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Primary,Cell Line Onboarding,Vendor,Bone,9,,,,,,,,,,Female,,,,
ACH-000878,HCC15,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,47,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000879,MFE296,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,68,,,,,,,,,,Female,,,2D Adherent,
ACH-000880,AGS,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Cell Line Onboarding,Vendor,stomach,54,,,,,,,,,,Female,,,2D Adherent,F12K + 10% FBS
ACH-000881,MELJUSO,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,58,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000882,IGR1,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,42,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000883,SW1783,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Primary,Cell Line Onboarding,Vendor,Central Nervous System,68,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000884,MDAMB435S,,,,,Skin Cancer,Melanoma: amelanotic,Amelanotic Melanoma (C3802),Metastasis,Cell Line Onboarding,Vendor,Skin,31,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000885,TOV21G,,,,,Ovarian Cancer,Adenocarcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Primary,Cell Line Onboarding,Vendor,Ovary,62,,,,,,,,,,Female,,,2D Adherent,MCDB 105:Medium 199 (1:1) + 15% FBS
ACH-000886,NCIH2009,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,68,,,,,,,,,,Female,,,,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 10nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000888,NCIH1793,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,52,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 30nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000889,KMM1,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,62,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000890,SW1271,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,69,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000891,HCC1438,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Primary,Cell Line Onboarding,Vendor,Lung,43,,,,,,,,,,Male,,,,
ACH-000892,NCIH1563,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-000893,NCIH1651,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,71,,,,,,,,,,Male,,,,
ACH-000894,NCIH1869,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,58,,,,,,,,,,Male,,,,
ACH-000895,CL34,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Colon,Unknown,,,,,,,,,,Female,,,,DMEM:F12 (1:1) + 20% FBS
ACH-000896,647V,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Primary,Cell Line Onboarding,Vendor,Urinary Tract,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 15% FBS + 2mM Glutamax
ACH-000897,FTC238,,,,,Thyroid Cancer,Carcinoma: follicular,Thyroid Gland Follicular Carcinoma (C8054),Metastasis,Cell Line Onboarding,Vendor,Lung,42,,,,,,,,,,Male,,,2D Adherent,
ACH-000898,SNU719,,,,,Gastric Cancer,Adenocarcinoma: tubular,Gastric Adenocarcinoma (C4004),Primary,Cell Line Onboarding,Vendor,stomach,53,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS + 2mM L-glutamine
ACH-000899,WM88,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Academic lab,Skin,Unknown,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000900,NCIH23,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,51,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000901,HCC1359,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Primary,Cell Line Onboarding,Vendor,Lung,55,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000904,NCIH2106,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,58,,,,,,,,,,Male,,,,
ACH-000905,5637,,,,,Bladder Cancer,Unknown,Bladder Carcinoma (C4912),Unknown,Cell Line Onboarding,Vendor,Urinary Tract,68,,,,,,,,,,Male,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000906,ES2,,,,,Ovarian Cancer,Carcinoma: clear cell,Ovarian Clear Cell Adenocarcinoma (C40078),Primary,Cell Line Onboarding,Vendor,Ovary,47,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000907,SNU349,,,,,Kidney Cancer,Renal Carcinoma: clear cell,Clear Cell Renal Cell Carcinoma (C4033),Primary,Cell Line Onboarding,Vendor,Kidney,68,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000908,SNU520,,,,,Gastric Cancer,Stomach Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Cell Line Onboarding,Vendor,stomach,60,,,,,,,,,,Female,,,2D Adherent,
ACH-000909,JHUEM2,,,,,Endometrial/Uterine Cancer,Uterine/Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,62,,,,,,,,,,Female,,,2D Mixed adherent and suspension,DMEM:F12 (1:1) + 10% FBS
ACH-000910,MDAMB453,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Pericardial Effusion,48,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000911,NUGC3,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,72,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000912,NCIH2286,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Primary,Cell Line Onboarding,Vendor,Lung,57,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + 1x Insulin-Transferrin-Selenium
ACH-000913,ESS1,,,,,Endometrial/Uterine Cancer,Endometrial Stromal Sarcoma,Endometrioid Stromal Sarcoma (C8973),Primary,Cell Line Onboarding,Vendor,Endometrium,76,,,,,,,,,,Female,,,2D Adherent,RPMI + 20% FBS
ACH-000914,HT,,,,,Lymphoma,B-cell: Non-Hodgkins,B-Cell Non-Hodgkin Lymphoma (C3457),Unknown,Cell Line Onboarding,Vendor,ascites,70,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000915,IPC298,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,64,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000916,NCIH1573,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,35,,,,,,,,,,Female,,,2D Adherent,RPMI + 5% FBS
ACH-000917,TE4,,,,,Esophageal Cancer,Squamous Cell Carcinoma,Esophageal Squamous Cell Carcinoma (C4024),Unknown,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000918,MOLT16,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,5,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000919,IM95,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Cell Line Onboarding,Vendor,stomach,63,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000920,CMLT1,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,36,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000921,NCIH1339,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,49,,,,,,,,,,Female,,,2D Adherent,RPMI + 20% FBS
ACH-000922,RCHACV,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,8,,,,,,,,,,Female,,,2D Suspension,RPMI + 20% FBS
ACH-000923,BCP1,,,,,Lymphoma,B-cell: Non-Hodgkins,B-Cell Non-Hodgkin Lymphoma (C3457),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,92,,,,,,,,,,Male,,,2D Adherent,RPMI + 20% FBS
ACH-000924,NCIH2172,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): unspecified,Non-Small Cell Lung Carcinoma (C2926),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000925,DV90,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,50,,,,,,,,,,Male,,,,
ACH-000926,HT55,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Unknown,,,2D Adherent,MEM + 20% FBS + Glutamine + NEAA
ACH-000927,BT474,,,,,Breast Cancer,Breast Ductal Carcinoma,Ductal Breast Carcinoma (C4017),Primary,Cell Line Onboarding,Vendor,Breast,60,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000928,JHUEM1,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,56,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 15% FBS
ACH-000929,NCIH2110,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): unspecified,Non-Small Cell Lung Carcinoma (C2926),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Unknown,,,2D Adherent,RPMI + 10% FBS
ACH-000930,HCC1569,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Primary,Cell Line Onboarding,Vendor,Breast,70,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000931,HMCB,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Primary,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Female,,,,
ACH-000932,SNU1,,,,,Gastric Cancer,Carcinoma,Gastric Carcinoma (C4911),Metastasis,Cell Line Onboarding,Vendor,stomach,44,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000933,SNU324,,,,,Pancreatic Cancer,Carcinoma,Pancreatic Carcinoma (C3850),Unknown,Cell Line Onboarding,Vendor,Pancreas,50,,,,,,,,,,Male,,,,RPMI + 10% heat inactivated FBS
ACH-000934,MDAMB361,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,Central Nervous System,40,,,,,,,,,,Female,,,2D Adherent,RPMI + 20% FBS
ACH-000935,MDST8,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Unknown,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Unknown,,,2D Adherent,DMEM + 10% FBS + 2mM Glutamine
ACH-000936,EFO27,,,,,Ovarian Cancer,Adenocarcinoma: endometrioid,Ovarian Endometrioid Adenocarcinoma (C7979),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,36,,,,,,,,,,Female,,,2D Adherent,RPMI + 20% FBS + 1mM Sodium pyruvate + 0.1mM NEAA
ACH-000938,NALM6,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,19,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 15% FBS
ACH-000939,SKUT1,,,,,Sarcoma,Leiomyosarcoma,Leiomyosarcoma (C3158),Primary,Cell Line Onboarding,Vendor,Endometrium,75,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000940,AN3CA,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Metastasis,Cell Line Onboarding,Vendor,Endometrium,55,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000941,HEC1B,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,71,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000942,HPBALL,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,14,Pediatric,,,,,,,,,Male,,,,
ACH-000943,RKO,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Colon,Unknown,,,,,,,,,,Unknown,,,2D Adherent,MEM + 10% FBS
ACH-000944,NAMALWA,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,3,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000945,NCIH650,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Bronchoalveolar Carcinoma,Bronchioloalveolar Carcinoma (C2923),Metastasis,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,ACL4
ACH-000946,HEC265,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 15% FBS
ACH-000947,OVK18,,,,,Ovarian Cancer,Adenocarcinoma: endometrioid,Ovarian Endometrioid Adenocarcinoma (C7979),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000948,2313287,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Primary,Cell Line Onboarding,Vendor,stomach,72,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000949,TGBC11TKB,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Female,,,2D Suspension,DMEM + 5% FBS
ACH-000950,LOVO,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,56,,,,,,,,,,Male,,,2D Adherent,F12 + 10% FBS + 2mM Glutamax + 1.5g/l Sodium bicarbonate
ACH-000951,NCIH2342,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,55,,,,,,,,,,Male,,,,
ACH-000952,MDAPCA2B,,,,,Prostate Cancer,Adenocarcinoma,Prostate Adenocarcinoma (C2919),Metastasis,Cell Line Onboarding,Vendor,Bone,63,,,,,,,,,,Male,,,,F12 + 20% FBS
ACH-000953,SUPT1,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,8,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000954,HEC1A,,,,,Endometrial/Uterine Cancer,Uterine/Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,71,,,,,,,,,,Female,,,2D Adherent,McCoy's 5A + 10% FBS
ACH-000955,SNU407,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Metastasis,Cell Line Onboarding,Vendor,Soft Tissue,37,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 2mM Glutamine
ACH-000956,22RV1,,,,,Prostate Cancer,Carcinoma,Prostate Carcinoma (C4863),Primary,Cell Line Onboarding,Vendor,Prostate,Unknown,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000957,LS180,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,58,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000958,SW48,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,82,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000960,REH,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,15,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000961,ISHIKAWAHERAKLIO02ER,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,39,,,,,,,,,,Female,,,,MEM + 10% FBS
ACH-000962,OC314,,,,,Ovarian Cancer,Cystadenocarcinoma: serous papillary,Ovarian Cystadenocarcinoma (C5228),Metastasis,Cell Line Onboarding,Vendor,ascites,39,,,,,,,,,,Female,,,,RPMI + 5% FBS + 2mM Glutamine
ACH-000963,CCK81,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS
ACH-000964,MOLT3,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,19,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-000965,RL952,,,,,Endometrial/Uterine Cancer,Adenosquamous Carcinoma,Endometrial Adenosquamous Carcinoma (C114656),Primary,Cell Line Onboarding,Vendor,Endometrium,65,,,,,,,,,,Female,,,2D Adherent,DMEM:F12  (1:1) + 5% FBS + 2mM L-glutamine + 5ug/ml Insulin + 0.01mg/ml Transferrin + 30nM Selenium + 10mM HEPES + 10nM Hydrocortisone + 10nM Beta estradiol
ACH-000966,IGROV1,,,,,Ovarian Cancer,Adenocarcinoma: endometrioid,Ovarian Endometrioid Adenocarcinoma (C7979),Primary,Cell Line Onboarding,Vendor,Ovary,47,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000967,SNUC2A,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Large Intestine,43,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-000968,COLO792,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Central Nervous System,62,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000969,KM12,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Unknown,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000970,SNUC5,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Unknown,Cell Line Onboarding,Vendor,Colon,77,,,,,,,,,,Female,,,,ACL4 + 20% heat inactivated FBS
ACH-000972,HEC151,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 15% FBS
ACH-000973,639V,,,,,Bladder Cancer,Transitional Cell Carcinoma,Bladder Urothelial Carcinoma (C39851),Primary,Cell Line Onboarding,Vendor,Urinary Tract,69,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000974,SNGM,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,52,,,,,,,,,,Female,,,2D Adherent,F12 + 20% FBS
ACH-000976,HUCCT1,,,,,Bile Duct Cancer,Cholangiocarcinoma: intrahepatic,Intrahepatic Cholangiocarcinoma (C35417),Metastasis,Cell Line Onboarding,Vendor,ascites,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000977,LNCAPCLONEFGC,,,,,Prostate Cancer,Adenocarcinoma,Prostate Adenocarcinoma (C2919),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,50,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000977,LNCAPCLONEFGC,,,,,Prostate Cancer,Adenocarcinoma,Prostate Adenocarcinoma (C2919),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,50,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000978,EN,,,,,Endometrial/Uterine Cancer,Endometrial Carcinoma,Endometrial Carcinoma (C7558),Primary,Cell Line Onboarding,Vendor,Endometrium,50,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000979,DU145,,,,,Prostate Cancer,Carcinoma,Prostate Carcinoma (C4863),Metastasis,Cell Line Onboarding,Vendor,Central Nervous System,69,,,,,,,,,,Male,,,,MEM + 10% FBS
ACH-000980,NCIH1155,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Large Cell Carcinoma,Large Cell Lung Carcinoma (C4450),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,36,,,,,,,,,,Male,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + NEAA
ACH-000981,DND41,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): T-cell,T Acute Lymphoblastic Leukemia (C3183),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,13,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 20% FBS
ACH-000982,GP2D,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Colon,71,,,,,,,,,,Female,,,,DMEM:F12 (1:1) + 10% FBS + Glutamine
ACH-000983,KCL22,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,32,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-000984,HEC6,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 15% FBS
ACH-000985,LS411N,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Primary,Cell Line Onboarding,Vendor,Large Intestine,32,,,,,,,,,,Male,,,,RPMI + 10% FBS
ACH-000986,HT115,,,,,Colon/Colorectal Cancer,Colon Carcinoma,Colon Carcinoma (C4910),Unknown,Cell Line Onboarding,Vendor,Colon,Unknown,,,,,,,,,,Unknown,,,2D Adherent,DMEM + 15% FBS + 2mM Glutamax
ACH-000987,MEWO,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,78,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-000988,MFE319,,,,,Endometrial/Uterine Cancer,Unknown,Endometrial Carcinoma (C7558),Unknown,Cell Line Onboarding,Vendor,Endometrium,81,,,,,,,,,,Female,,,2D Adherent,RPMI:MEM (1:1) + 20% heat inactivated FBS
ACH-000989,SNU175,,,,,Colon/Colorectal Cancer,Colorectal Carcinoma: mucinous,Colorectal Carcinoma (C2955),Metastasis,Cell Line Onboarding,Vendor,Abdominal Cavity,56,,,,,,,,,,Female,,,2D Mixed adherent and suspension,RPMI + 10% FBS
ACH-000990,HEC108,,,,,Endometrial/Uterine Cancer,Uterine/Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,Unknown,,,,,,,,,,Female,,,,
ACH-000991,SNU81,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Unknown,Cell Line Onboarding,Vendor,Colon,53,,,,,,,,,,Male,,,,RPMI + 10% heat inactivated FBS + 2mM Glutamine + HEPES + Sodium bicarbonate
ACH-000992,BICR18,,,,,Head and Neck Cancer,Squamous Cell Carcinoma,Head and Neck Squamous Cell Carcinoma (C34447),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,Unknown,,,,,,,,,,Male,,,,DMEM + 10% FBS
ACH-000993,JHUEM7,,,,,Endometrial/Uterine Cancer,Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,58,,,,,,,,,,Female,,,2D Adherent,DMEM:F12 (1:1) + 10% FBS + NEAA
ACH-000994,HEC59,,,,,Endometrial/Uterine Cancer,Uterine/Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 15% FBS
ACH-000996,HEC251,,,,,Endometrial/Uterine Cancer,Uterine/Endometrial Adenocarcinoma,Endometrial Adenocarcinoma (C7359),Primary,Cell Line Onboarding,Vendor,Endometrium,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 0.15% FBS
ACH-000997,HCT15,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Male,,,,
ACH-000998,CW2,,,,,Colon/Colorectal Cancer,Colorectal Carcinoma,Colorectal Carcinoma (C2955),Primary,Cell Line Onboarding,Vendor,Large Intestine,55,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000999,SNU1040,,,,,Colon/Colorectal Cancer,Colorectal Carcinoma,Colorectal Carcinoma (C2955),Unknown,Cell Line Onboarding,Vendor,Colon,34,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-001000,1321N1,,,,,Brain Cancer,Astrocytoma,Astrocytoma (C60781),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,Unknown,,,,,,,,,,Male,,,,
ACH-001001,143B,,,,,Bone Cancer,Osteosarcoma,Osteosarcoma (C9145),Primary,Cell Line Onboarding,Vendor,Bone,13,Pediatric,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS + 15ug/ml 5-BrdU
ACH-001011,ACCS,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Unknown,Cell Line Onboarding,Unknown,Urinary Tract,81,,,,,,,,,,Female,,,,
ACH-001015,AZ521,,,,,Gastric Cancer,Duodenal Adenocarcinoma,Duodenal Adenocarcinoma (C7889),Unknown,Cell Line Onboarding,Unknown,stomach,Unknown,,,,,,,,,,Male,,,,
ACH-001016,BECKER,,,,,Brain Cancer,Glioma,Glioma (C3059),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,57,,,,,,,,,,Male,,,,
ACH-001017,BGC823,,,,,Gastric Cancer,Adenocarcinoma,Gastric Adenocarcinoma (C4004),Unknown,Cell Line Onboarding,Unknown,stomach,62,,,,,,,,,,Male,,,,
ACH-001021,C3A,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Unknown,Cell Line Onboarding,Vendor,Liver,15,,,,,,,,,,Male,,,,
ACH-001023,CGTHW1,,,,,Thyroid Cancer,Carcinoma: follicular,Thyroid Gland Follicular Carcinoma (C8054),Metastasis,Cell Line Onboarding,Vendor,thyroid,70,,,,,,,,,,Unknown,,,,
ACH-001024,CHL1,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Female,,,,
ACH-001036,CMK115,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS
ACH-001039,COLO205,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Metastasis,Cell Line Onboarding,Vendor,ascites,70,,,,,,,,,,Male,,,,
ACH-001040,COLO677,,,,,Leukemia,Unknown,Leukemia (C3161),Unknown,Cell Line Onboarding,Unknown,Haematopoietic and Lymphoid Tissue,61,,,,,,,,,,Male,,,,
ACH-001041,COLO699,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,57,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-001042,COLO704,,,,,Ovarian Cancer,Adenocarcinoma,Ovarian Adenocarcinoma (C7700),Metastasis,Cell Line Onboarding,Vendor,ascites,46,,,,,,,,,,Female,,,,RPMI + 10% FBS
ACH-001043,COLO775,,,,,Myeloma,Plasma Cell,Plasma Cell Myeloma (C3242),Unknown,Cell Line Onboarding,Unknown,Haematopoietic and Lymphoid Tissue,57,,,,,,,,,,Unknown,,,,
ACH-001044,COLO818,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,Unknown,,,,,,,,,,Male,,,,
ACH-001047,CORL51,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Unknown,Pleural Effusion,71,,,,,,,,,,Male,,,,
ACH-001048,COV504,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS + 2mM L-glutamine
ACH-001049,CPCN,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,Unknown,,,,,,,,,,Male,,,,
ACH-001058,DFCI024,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Unknown,Cell Line Onboarding,Unknown,Lung,Unknown,,,,,,,,,,Female,,,,
ACH-001061,DLD1,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Primary,Cell Line Onboarding,Vendor,Large Intestine,Unknown,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS
ACH-001064,EB2,,,,,Lymphoma,B-cell: Non-Hodgkins: Burkitts,Burkitt Lymphoma (C2912),Unknown,Cell Line Onboarding,Vendor,Ovary,7,,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-001065,EVSAT,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Unknown,ascites,Unknown,,,,,,,,,,Female,,,,
ACH-001071,GLC82,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,58,,,,,,,,,,Female,,,,
ACH-001072,GRM,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Unknown,Cell Line Onboarding,Unknown,Skin,36,,,,,,,,,,Male,,,,
ACH-001075,NCIH292,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Mucoepidermoid Carcinoma,Lung Mucoepidermoid Carcinoma (C45544),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,32,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-001078,HCC1588,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,63,,,,,,,,,,Female,,,,
ACH-001080,HCC2373,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): unspecified,Non-Small Cell Lung Carcinoma (C2926),Unknown,Cell Line Onboarding,Unknown,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-001084,HCT8,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Unknown,Cell Line Onboarding,Unknown,Large Intestine,67,,,,,,,,,,Male,,,,
ACH-001085,HEK293,,,,,Kidney Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma (C9385),Unknown,Cell Line Onboarding,Unknown,Kidney,Unknown,,,,,,,,,,Unknown,,,,
ACH-001088,HLC1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Metastasis,Cell Line Onboarding,Unknown,Pleural Effusion,Unknown,,,,,,,,,,Unknown,,,,
ACH-001089,HLE,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Unknown,Cell Line Onboarding,Vendor,Liver,68,,,,,,,,,,Male,,,,
ACH-001090,HN,,,,,Head and Neck Cancer,Squamous Cell Carcinoma: oral,Oral Cavity Squamous Cell Carcinoma (C4833),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,60,,,,,,,,,,Male,,,,
ACH-001091,HRT18,,,,,Colon/Colorectal Cancer,Colorectal Adenocarcinoma,Colorectal Adenocarcinoma (C5105),Unknown,Cell Line Onboarding,Unknown,Large Intestine,67,,,,,,,,,,Male,,,,
ACH-001093,HS604T,,,,,Fibroblast,Lymphoma,Fibroblast,Unknown,Cell Line Onboarding,Vendor,Lymph Node,21,,,,,,,,,,Male,,,,
ACH-001094,HTK,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Female,,,,
ACH-001098,KCIMOH1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Cell Line Onboarding,Vendor,Pancreas,64,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-001101,KLM1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Metastasis,Cell Line Onboarding,Vendor,Liver,Unknown,,,,,,,,,,Male,,,,
ACH-001106,KOPN8,,,,,Leukemia,Acute Lymphoblastic Leukemia (ALL): B-cell,B Acute Lymphoblastic Leukemia (C8644),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,0.25,Pediatric,,,,,,,,,Female,,,2D Suspension,RPMI + 10% FBS
ACH-001107,KP1N,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Cell Line Onboarding,Unknown,Pancreas,69,,,,,,,,,,Male,,,,
ACH-001108,KP1NL,,,,,Pancreatic Cancer,Carcinoma,Pancreatic Carcinoma (C3850),Metastasis,Cell Line Onboarding,Unknown,Pancreas,69,,,,,,,,,,Male,,,,
ACH-001112,LC1,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Unknown,Cell Line Onboarding,Unknown,Lung,Unknown,,,,,,,,,,Unknown,,,,
ACH-001113,LC1SQSF,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,69,,,,,,,,,,Male,,,2D Adherent,RPMI + 10% FBS + 1% HEPES
ACH-001118,M059J,,,,,Brain Cancer,Glioma,Glioma (C3059),Unknown,Cell Line Onboarding,Unknown,Central Nervous System,Unknown,,,,,,,,,,Male,,,,
ACH-001120,MB157,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Unknown,Cell Line Onboarding,Unknown,Breast,48,,,,,,,,,,Female,,,,
ACH-001121,MEC2,,,,,Lymphoma,B-cell: unspecified,B-Cell Non-Hodgkin Lymphoma (C3457),Unknown,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,62,,,,,,,,,,Male,,,,
ACH-001125,MOGGCCM,,,,,Brain Cancer,Glioma,Glioma (C3059),Unknown,Cell Line Onboarding,Unknown,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,
ACH-001126,MOGGUVW,,,,,Brain Cancer,Glioma,Glioma (C3059),Unknown,Cell Line Onboarding,Unknown,Central Nervous System,Unknown,,,,,,,,,,Male,,,,
ACH-001129,MONOMAC1,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,64,Pediatric,,,,,,,,,Male,,,2D Suspension,RPMI + 10% FBS + 2mM Glutamine + 1mM Sodium pyruvate + 0.1mM NEAA
ACH-001138,NCIH2141,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,Lymph Node,58,,,,,,,,,,Male,,,,
ACH-001141,NCIH969,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Unknown,Cell Line Onboarding,Unknown,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-001144,OC315,,,,,Ovarian Cancer,Adenocarcinoma: serous,Ovarian Serous Adenocarcinoma (C7550),Unknown,Cell Line Onboarding,Vendor,Ovary,49,,,,,,,,,,Female,,,,
ACH-001145,OC316,,,,,Ovarian Cancer,Adenocarcinoma: serous,Ovarian Serous Adenocarcinoma (C7550),Metastasis,Cell Line Onboarding,Vendor,ascites,60,,,,,,,,,,Female,,,2D Adherent,RPMI + 5% FBS
ACH-001146,OCILY10,,,,,Lymphoma,Diffuse Large B-cell Lymphoma (DLBCL),Diffuse Large B-Cell Lymphoma (C8851),Unknown,Cell Line Onboarding,Unknown,Lymph Node,Unknown,,,,,,,,,,Female,,,,
ACH-001150,OUMS27,,,,,Bone Cancer,Chondrosarcoma,Chondrosarcoma (C2946),Primary,Cell Line Onboarding,Vendor,Bone,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-001151,OVCAR5,,,,,Ovarian Cancer,Adenocarcinoma: high grade serous,High Grade Ovarian Serous Adenocarcinoma (C105555),Metastasis,Cell Line Onboarding,Academic lab,ascites,Unknown,,,,,,,,,,Female,,,2D Adherent,RPMI + 5% FBS
ACH-001162,PCM6,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Primary,Cell Line Onboarding,Vendor,Haematopoietic and Lymphoid Tissue,Unknown,,,,,,,,,,Female,,,,
ACH-001171,PL45,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Unknown,Cell Line Onboarding,Vendor,Pancreas,Unknown,,,,,,,,,,Male,,,,
ACH-001183,RT11284,,,,,Bladder Cancer,Carcinoma,Bladder Carcinoma (C4912),Unknown,Cell Line Onboarding,Vendor,Urinary Tract,Unknown,,,,,,,,,,Female,,,2D Adherent,MEM + 10% FBS + 1% NEAA + 2mM Glutamax
ACH-001185,SF763,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Cell Line Onboarding,Unknown,Central Nervous System,Unknown,,,,,,,,,,Female,,,,
ACH-001186,SF782,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Cell Line Onboarding,Unknown,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,
ACH-001187,SF8657,,,,,Fibroblast,,Fibroblast,Unknown,Cell Line Onboarding,Unknown,Skin,63,,,,,,,,,,Male,,,,
ACH-001188,SHSY5Y,,,,,Neuroblastoma,Unknown,Neuroblastoma (C3270),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,4,Pediatric,,,,,,,,,Female,,,2D Adherent,MEM:F12 (1:1) + 10% FBS
ACH-001189,SJRH30,,,,,Sarcoma,Rhabdomyosarcoma,Rhabdomyosarcoma (C3359),Metastasis,Cell Line Onboarding,Vendor,Bone Marrow,17,,,,,,,,,,Male,,,,
ACH-001190,SKMEL2,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,60,,,,,,,,,,Male,,,2D Adherent,MEM + 10% FBS
ACH-001198,SNB19,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Vendor,Central Nervous System,47,,,,,,,,,,Male,,,,
ACH-001199,SNUC2B,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Unknown,Cell Line Onboarding,Unknown,Large Intestine,43,,,,,,,,,,Female,,,,
ACH-001203,SUPHD1,,,,,Lymphoma,B-cell: Hodgkins,Hodgkin Lymphoma (C9357),Unknown,Cell Line Onboarding,Vendor,Pleural Effusion,37,,,,,,,,,,Male,,,,
ACH-001207,TIG3TD,,,,,Fibroblast,Lung,Fibroblast,Unknown,Cell Line Onboarding,Unknown,Fibroblast,Unknown,,,,,,,,,,Unknown,,,,
ACH-001208,TK10,,,,,Kidney Cancer,Unknown,Kidney Carcinoma (C9384),Unknown,Cell Line Onboarding,Unknown,Kidney,Unknown,,,,,,,,,,Male,,,,
ACH-001213,U138,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Unknown,Cell Line Onboarding,Unknown,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,
ACH-001214,U138MG,,,,,Brain Cancer,Glioma,Glioma (C3059),Unknown,Cell Line Onboarding,Vendor,Central Nervous System,50,,,,,,,,,,Male,,,,
ACH-001217,U373MG,,,,,Brain Cancer,Glioblastoma,Glioblastoma (C3058),Primary,Cell Line Onboarding,Unknown,Central Nervous System,Unknown,,,,,,,,,,Unknown,,,,
ACH-001230,UT7,,,,,Leukemia,Acute Myelogenous Leukemia (AML),Acute Myeloid Leukemia (C3171),Unknown,Cell Line Onboarding,Vendor,Bone Marrow,64,,,,,,,,,,Male,,,,
ACH-001231,UTMC2,,,,,Myeloma,Multiple Myeloma,Plasma Cell Myeloma (C3242),Unknown,Cell Line Onboarding,Unknown,Pleural Effusion,Unknown,,,,,,,,,,Female,,,,
ACH-001233,VMRCLCD,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,,
ACH-001234,VMRCLCP,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Squamous Cell Carcinoma,Squamous Cell Lung Carcinoma (C3493),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Unknown,,,,
ACH-001239,WM2664,,,,,Skin Cancer,Melanoma,Cutaneous Melanoma (C3510),Metastasis,Cell Line Onboarding,Vendor,Skin,58,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-001249,YMB1,,,,,Breast Cancer,Carcinoma,Breast Carcinoma (C4872),Metastasis,Cell Line Onboarding,Vendor,ascites,63,,,,,,,,,,Female,,,,
ACH-001282,CHLA258,,,,,Bone Cancer,Ewings Sarcoma,Ewing Sarcoma of Bone (C4835),Unknown,Cell Line Onboarding,Academic lab,Bone,Unknown,Pediatric,,,,,,,,,Female,,,2D Adherent,IMDM + 20% FBS + 4mM Glutamine + 1x Insulin-Transferrin-Selenium
ACH-001306,8305C,,,,,Thyroid Cancer,Carcinoma,Thyroid Gland Carcinoma (C4815),Primary,Cell Line Onboarding,Vendor,thyroid,67,,,,,,,,,,Female,,,2D Adherent,RPMI + 15% FBS
ACH-001307,8505C,,,,,Thyroid Cancer,Carcinoma,Thyroid Gland Carcinoma (C4815),Primary,Cell Line Onboarding,Vendor,thyroid,78,,,,,,,,,,Female,,,2D Adherent,MEM + 0.1% FBS
ACH-001318,PLCPRF5,,,,,Liver Cancer,Hepatocellular Carcinoma,Hepatocellular Carcinoma (C3099),Primary,Cell Line Onboarding,Vendor,Liver,24,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-001432,SNU408,,,,,Pancreatic Cancer,Unknown,Pancreatic Carcinoma (C3850),Unknown,Cell Line Onboarding,Unknown,Pancreas,Unknown,,,,,,,,,,Unknown,,,,
ACH-000959,SNUC4,,,,,Colon/Colorectal Cancer,Colon Adenocarcinoma,Colon Adenocarcinoma (C4349),Unknown,Cell Line Onboarding,Vendor,Large Intestine,35,,,,,,,,,,Male,,,2D Suspension,RPMI + 10% heat inactivated FBS + 300mg/L L-glutamine + 25mM HEPES + 25mM Sodium bicarbonate
ACH-000551,K562,,,,,Leukemia,Chronic Myelogenous Leukemia (CML): blast crisis,Blast Phase Chronic Myelogenous Leukemia: BCR-ABL1 Positive (C9110),Metastasis,Cell Line Onboarding,Vendor,Pleural Effusion,53,,,,,,,,,,Female,,,2D Suspension,IMDM + 10% FBS
ACH-000587,NCIH1975,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Female,,,2D Adherent,DMEM + 10% FBS
ACH-000667,HCC44,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): Adenocarcinoma,Lung Adenocarcinoma (C3512),Primary,Cell Line Onboarding,Vendor,Lung,54,,,,,,,,,,Female,,,2D Adherent,RPMI + 10% FBS
ACH-000826,CAL12T,,,,,Lung Cancer,Non-Small Cell Lung Cancer (NSCLC): unspecified,Non-Small Cell Lung Carcinoma (C2926),Primary,Cell Line Onboarding,Vendor,Lung,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000048,TOV112D,,,,,Ovarian Cancer,Adenocarcinoma: endometrioid,Ovarian Endometrioid Adenocarcinoma (C7979),Primary,Cell Line Onboarding,Vendor,Ovary,42,,,,,,,,,,Female,,,2D Adherent,MCDB 105:Medium 199 (1:1) + 15% FBS + 1.5g/l Sodium bicarbonate
ACH-000164,PANC1,,,,,Pancreatic Cancer,Ductal Adenocarcinoma: exocrine,Pancreatic Ductal Adenocarcinoma (C9120),Primary,Cell Line Onboarding,Vendor,Pancreas,Unknown,,,,,,,,,,Male,,,2D Adherent,DMEM + 10% FBS
ACH-000685,L33,,,,,Pancreatic Cancer,Ductal Adenosquamous Carcinoma,Pancreatic Carcinoma (C3850),Metastasis,Cell Line Onboarding,Academic lab,Lymph Node,Unknown,,,,,,,,,,Female,,,2D Mixed adherent and suspension,DMEM + 10% FBS + 2mM Glutamine + 1mM Sodium pyruvate + 1mM NEAA
ACH-000090,PC3,,,,,Prostate Cancer,Adenocarcinoma,Prostate Adenocarcinoma (C2919),Metastasis,Cell Line Onboarding,Vendor,Bone,62,,,,,,,,,,Male,,,2D Adherent,F12 + 10% FBS
ACH-000431,NCIH1694,,,,,Lung Cancer,Small Cell Lung Cancer (SCLC),Small Cell Lung Carcinoma (C4917),Metastasis,Cell Line Onboarding,Vendor,ascites,61,,,,,,,,,,Male,,,2D Suspension,F12 + 10% FBS
ACH-000903,FTC133,,,,,Thyroid Cancer,Carcinoma: anaplastic,Thyroid Gland Undifferentiated (Anaplastic) Carcinoma (C3878),Metastasis,Cell Line Onboarding,Vendor,thyroid,42,,,,,,,,,,Male,,,,DMEM:F12 (1:1) + 10% FBS + 2mM Glutamine